WO2005000354A1 - 排尿障害予防・治療剤 - Google Patents
排尿障害予防・治療剤 Download PDFInfo
- Publication number
- WO2005000354A1 WO2005000354A1 PCT/JP2004/009486 JP2004009486W WO2005000354A1 WO 2005000354 A1 WO2005000354 A1 WO 2005000354A1 JP 2004009486 W JP2004009486 W JP 2004009486W WO 2005000354 A1 WO2005000354 A1 WO 2005000354A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- group
- alkyl
- indole
- ring
- substituent
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/914—Hydrolases (3)
- G01N2333/916—Hydrolases (3) acting on ester bonds (3.1), e.g. phosphatases (3.1.3), phospholipases C or phospholipases D (3.1.4)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
- G01N2500/04—Screening involving studying the effect of compounds C directly on molecule A (e.g. C are potential ligands for a receptor A, or potential substrates for an enzyme A)
Definitions
- the present invention relates to a medicament, more specifically, a prophylactic / therapeutic agent for dysuria, a prophylactic / therapeutic agent for uropathy induced by administration of a therapeutic agent for dysuria, a therapeutic agent for prevention of overactive bladder without uropathy, and a screening method thereof.
- Overactive bladder here
- Bl adder is a symptom or disease that has urinary urgency as the main symptom, is often accompanied by frequent urination and nocturia, and sometimes causes urinary incontinence.
- Urination disorder is a general term for subjective or objective abnormalities in the process of urine accumulation (urinary collection) to excretion (urination), urinary storage disorder (urinary incontinence, frequent urination, etc.), urinary disturbance (urinary difficulty, urination) Pain, urinary tract obstruction, etc.).
- urinary tract diseases of the elderly, especially urination disorders have become a major social problem.
- Dysuria is caused by obstruction of the urethra, insufficiency of the detrusor muscle, impaired coordination of the detrusor muscles, or a combination of the two.
- the underlying diseases or causes are brain and spinal cord diseases, prostatic hypertrophy, diabetes, and pelvic disorders. Surgery, aging, etc. vary. Physically enhancing the bladder emptying function can be considered by relaxing the urethra and reducing urethral resistance, or by increasing the bladder's contractile force during urination.
- Blockers are widely used for relaxation of the urethra and are the first-line drug for urethral obstruction associated with benign prostatic hyperplasia.
- distigmine bromi de a carbamate acetylcholine esterase inhibitor, and neostigmine methyl sulphate (neos t igmine me thylsul fat), which are carbamate acetylcholinesterase inhibitory moldings, are used to enhance bladder contractility.
- neostigmine methyl sulphate neos t igmine me thylsul fat
- betanechol chloride be thanecho chloride
- acetylcholine is hydrolyzed and deactivated by acetylcholinesterase present on the membrane and nonspecific cholinesterase (butyrylcholinesterase), which is a free protein.
- acetylcholinesterase and butyrylcholinesterase also coexist in bladder smooth muscle, and both enzymes are thought to be involved in the degradation of released acetylcholine (see, for example, The Anatomical Record, 1996, No. 245). Vol., Pp. 645-641).
- Acetylcholinesterase and butyrylcholinesterase activities can be measured in vitro, There have been many reports of drugs that inhibit the activity of.
- Estella-1 Estella-1 (putyrylcholine drug inhibitor inhibitory activity inhibitory esterase / Article
- acetylacetylcholinesterase plays a more important role in the regulation of bladder contraction by acetylcholine among the above two cholinesterases.
- International Publication No. 0Z188391 pamphlet states that a non-potency rubamate-based amine compound having acetylcholinesterase inhibitory activity improves bladder excretion and is effective in treating dysuria, especially dysuria It is disclosed.
- International Publication No. 03/57252 5 describes a compound having both an acetylcholine esterase inhibitory action and an antagonistic action, and describes that it is effective for the treatment of dysuria. ing.
- Rhodolin is caused by anticholinergic drugs acting in the salivary glands (submandibular gland, parotid gland) antagonistically to acetylcholine, which stimulates salivation.
- Muscarinic M 3 receptors of acetylcholine is a receptor that plays a most significant role in the contraction of the bladder, which is a receptor for the saliva secretion is also involved large at the same time in the salivary glands. Therefore, it is difficult to create an anticholinergic agent that aims at the pharmacological action of the new compound from the overactive bladder inhibitory action and the salivary secretion inhibitory action from the pharmacological action. At present, it has been reported that sustained release or changes in dosage forms such as transdermal absorption agents can reduce side effects, but the incidence of oral disorders is still high.
- the present invention has a higher therapeutic effect and convenience than known acetylcholinesterase inhibitors known to have a therapeutic effect on dysuria, and has few side effects.
- An object of the present invention is to provide a substance and a method for screening the substance, and to provide a means for preventing and treating dysuria using the substance.
- the present inventors have conducted intensive studies in order to solve the above-mentioned problems.
- a compound having substantially no inhibitory action on ptyrylcholinesterase was urethane.
- pressure / flow studies using anaesthetized guinea pigs we found that parametrial drainage was enhanced without affecting the urinary storage of the bladder.
- distigmine peneostigmine an acetylcholinesterase inhibitor that also inhibits petyrylcholinesterase, reduces bladder urinary storage due to reduced bladder compliance, and increases urethral resistance due to contraction of the external urethral sphincter.
- the acetylcholinesterase-selective inhibitor is an effective prophylactic / therapeutic agent against uropathy induced by administration of the prophylactic / therapeutic agent for dysuria.
- a prophylactic or therapeutic agent for dysuria for example, an anticholinergic agent 4009486
- the above-mentioned acetylcholinesterase selective inhibitor acts antagonistically on the activity (suppression of salivary secretion).
- the acetylcholinesterase-selective inhibitor does not affect the action of increasing the bladder S light capacity of the preventive / therapeutic agent for micturition disorders and is useful as a preventive / therapeutic agent for overactive bladder, without accompanying radiation Turned out to be.
- a prophylactic / therapeutic agent for dysuria which does not inhibit the urinary storage function, comprising a compound having acetylcholinesterase inhibitory activity and having substantially no putyrylcholinesterase inhibitory activity,
- a prophylactic / therapeutic agent for uropathy induced by administration of a therapeutic agent for dysuria comprising a compound having an acetylcholinesterase inhibitory activity and having substantially no putyrylcholinesterase inhibitory activity;
- a prophylactic / therapeutic agent for overactive bladder, without rosin comprising a combination of a compound having acetylcholinesterase inhibitory activity and having substantially no putyrylcholinesterase inhibitory activity and an anticholinergic agent ,
- a compound having an acetylcholinesterase inhibitory activity and substantially having no ptyrylcholinesterase inhibitory activity for producing a prophylactic and / or therapeutic agent for overactive bladder, which is not accompanied by glucose, and an anticholinergic agent Use of,
- a prophylactic and therapeutic agent for overactive bladder without b) comprising a compound having an acetylcholinesterase inhibitory activity and having substantially no petrylcholinesterase inhibitory activity;
- [16] has an acetylcholinesterase inhibitory activity against mammals, and 6
- the present invention relates to use of a compound having acetylcholinesterase inhibitory activity and having substantially no ptyrylcholinesterase inhibitory activity for producing a prophylactic and / or therapeutic agent for overactive bladder, which is not accompanied by glucose.
- a compound that has AChE inhibitory activity and does not have BuChE inhibitory activity enhances the contractile action of the detrusor muscle only at the time of urination without lowering bladder compliance during the urine storage period, so that the compound is safe and effective without side effects It is extremely useful as a preventive and therapeutic agent for dysuria, and also as a preventive and therapeutic agent for uropathy induced by administration of a therapeutic agent for dysuria. Useful.
- Compound having acetylcholinesterase (hereinafter sometimes abbreviated as AChE) inhibitory activity and having substantially no ptyrylcholinesterase (hereinafter sometimes abbreviated as BuChE) inhibitory activity” used in the present invention is a compound that has an AChE inhibitory activity sufficient to improve detrusor dysfunction during urination and has substantially a BuChE inhibitory activity.
- a compound having no BuChE inhibitory activity that is, having no BuChE inhibitory activity or having a low BuChE inhibitory activity that does not increase the basal tension of the detrusor muscle during urination.
- the AChE inhibitory activity of the compound of the present invention is determined by measuring the AChE value obtained by the chocholine method (Elman method: a measurement method used in the in vitro enzyme inhibition test of Test Example 1 described later).
- The% inhibitory concentration (IC 5 ) value is about 0.2 or less, more preferably about 0.2 M or less.
- the BuChE inhibitory activity of the compound of the present invention is preferably such that the 50% inhibitory concentration (IC 5 ) value of BuChE obtained by the chocholine method (as described above) is about l ⁇ M or more, and more preferably about 1 ⁇ M. 0 M or more.
- the preventive / therapeutic agent for dysuria comprising the compound of the present invention is characterized by not inhibiting the urinary storage function.
- does not inhibit the urinary storage function means that the administration of the drug does not shorten the onset time of the first urination, or does not significantly reduce the bladder compliance and Z or bladder capacity as compared to before administration. .
- Prevention and treatment of uropathy induced by the administration of a therapeutic agent for dysuria comprising the compound of the present invention is effective in preventing and treating uropathy induced by administration of a therapeutic agent such as an anticholinergic agent. It is characterized by doing.
- the therapeutic agent for the prevention of overactive bladder without containing the compound of the present invention is used when the compound of the present invention itself is used as a therapeutic agent for the prevention and treatment of overactive bladder, or for the prevention of other overactive bladder.
- a therapeutic agent such as an anticholinergic agent
- the compound of the present invention may have any molecular structure as long as it has AChE inhibitory activity as defined herein and does not substantially have BuChE inhibitory activity.
- an amine compound in which a hydrogen atom of ammonia is substituted with a hydrocarbon group is preferable, and a primary amine compound, a secondary amine compound, and a tertiary amine compound are more preferable.
- One of such amine compounds is, for example, an amine compound having no olebamate structure (one OCON—) in a molecule such as 1) to 49) described below (hereinafter referred to as compound A). In some cases).
- compound A an amine compound having no olebamate structure (one OCON—) in a molecule such as 1) to 49) described below (hereinafter referred to as compound A).
- compounds having at least one 5- to 7-membered nitrogen-containing heterocyclic ring as a partial structure are preferred, and among them, the following 1), 20), 23) and 41) , 42) and 43) are preferred, and 1) is particularly preferred.
- amine compounds include, for example, salts such as salts and prodrugs of the following compounds (II), (Ila), (lib), (lie) or (Iid). Changes to a compound that has both acetylcholine esterase inhibitory action and ⁇ 1 antagonistic action. Or a compound that converts into a compound having both acetylcholinesterase inhibitory activity and K1 antagonism by a reaction with an enzyme, gastric acid, or the like under physiological conditions in vivo (hereinafter sometimes referred to as compound B). ).
- Compound A has the formula
- Ar is a phenyl group which may be condensed, and the phenyl group may have a substituent
- ⁇ is an integer from 1 to 10;
- ⁇ represents an amino group which may have a substituent or a nitrogen-containing saturated heterocyclic group which may have a substituent. (Hereinafter may be abbreviated as compound (I)) or a salt thereof.
- the “substituent” in Ar “a phenyl group which may be condensed, and the phenyl group may have a substituent” includes, for example, (i) halogen (Ii) a halogen atom (for example, fluoro, chloro, bromo, and the like); (iii) a lower alkylenedioxy group (for example, methyldioxy, ethylenedioxy, etc.
- cyclohexane - 6 consequent opening alkyl group (ix) optionally halogenated substituted lower alkylthio group, (X) amino group, (xi) mono One low grade Alkylamino group (e.g., Mechiruamino, Echiruamino, mono- and propyl amino - 6 alkylamino group, etc.), (xi i) Di-lower alkylamino groups (for example, di- 6 alkylamino groups such as dimethylamino and getylamino), (xiii) 5- to 7-membered cyclic amino groups (for example, nitrogen atom, oxygen atom and sulfur other than one nitrogen atom) A 5- to 7-membered cyclic amino group which may have 1 to 3 heteroatoms selected from atoms and the like (eg, pyrrolidino, piperidino, piperazino, morpholino, thiomorpholino, etc.), (xiv) lower Alkyl monopheny
- benzyl, mono one phenylene Lou such Fueniruechiru - 6 alkyl group
- diphenyl lower alkyl group for example, diphenyl Chill, such as Jifueniruechiru Jifue two Lou - 6 An alkyl group, etc.
- monophenyl lower alkyl-carponyloxy group for example, a mono-phenyl- 6- alkyl mono-l-ponyloxy group such as phenylmethylcarbonyloxy, phenylethylcarboxyloxy, etc.
- XXX Diphenyl lower alkyl monophenyloxy group (for example, diphenylethyl carbonyloxy, diphenylethylcarbonyl, etc.)
- C x _ 6 alkyl monofunctional phenyloxy group, etc. (xxxi) phenoxy group, (xxxi i) monophenyl lower alkyl-functional propylonyl group (for example, monophenyl carbonyl such as phenylmethylcarbonyl, phenylethylcarbonyl, etc. _ 6 Alkyl-carbonyl group, etc.), (xxxi ii) diphenyl lower alkyl monopropyl group (for example, diphenyl methylcarbonyl, diphenylethylcarbonyl, etc.
- _ 6 alkyl, etc. lower alkoxy (e.g., methoxy, ethoxy, Purobokishi, Isopurobokishi, butoxy, isobutoxy, sec- butoxy, _ 6 alkoxy such as ter t-butoxy), halogen atom (e.g., click Rolle, bromine , A hydroxy group, a benzyloxy group, an amino group, a mono-lower alkylamino group (for example, mono- 6 alkylamino such as methylamino, ethylamino, propylamino, etc.), a di-lower alkylamino group (for example, Di- ⁇ - 6- alkylamino such as dimethylamino, getylamino, etc.), nitro group, lower alkyl-carbonyl group (eg, methyl- 6- alkyl- 6, such as methylcarbonyl, ethylcarbonyl, butylcarbonyl, etc.), benzo
- the phenyl group may have 1 to 4 of these substituents.
- optionally halogenated lower alkyl group include, for example, a lower alkyl group which may have 1 to 3 halogen atoms (for example, chloro, bromo, and the like) (for example, , methyl, Echiru, propyl, isopropyl, butyl, sec- butyl, ter t-butyl, pentyl, _ 6 Al kill group) or the like hexyl, and the like to, and specific examples include methyl, chloromethyl, Jifuruo Romethyl, trichloromethyl, trifluoromethyl, ethyl, 2-bromoethyl, 2,2,2-trifluoroethyl, propyl, 3,3,3-trifluorotrifluoropropyl, isopropyl, butyl, 4,4,4-trifluoro O-butyl, is
- optionally lower alkoxy group examples include, for example, a lower alkoxy group optionally having .1 to 3 halogen atoms (for example, chloro, bromo, and odo). for example, methoxy, ethoxy, Purobokishi, I Sopurobokishi, butoxy, isobutanol Bok alkoxy, sec- butoxy, etc. C!
- _ 6 alkoxy group such as ter t-butoxy
- specific examples include, for example, methoxy, Ziv Ruorometokishi , Trifluoromethoxy, ethoxy, 2,2,2-trifluoro ethoxy, propoxy, isopropoxy, butoxy, 4,4,4-trifluorobutoxy, isobutoxy, sec-butoxy, pentyloxy, hexyloxy, etc. .
- Examples of the “optionally halogenated lower alkylthio group” include, for example, a lower alkylthio group optionally having 1 to 3 halogen atoms (for example, chloro, bromo, and odo) (for example, Methylthio, ethylthio, propylthio, isopropylthio, butylthio, isobutylthio, sec-butylthio, tert-butylthio, etc.- 6 alkylthio groups, etc.).
- halogen atoms for example, chloro, bromo, and odo
- methylthio difluoromethylthio, trifluoromethyl
- examples include methylthio, ethylthio, propylthio, isopropylthio, butylthio, 4,4,4-trifluorobutylthio, isobutylthio, sec-butylthio, tert-butylthio, pentylthio, hexylthio and the like.
- a substituent of “a phenyl group which may be condensed and the phenyl group may have a substituent”, (i) an amino group, (ii) a mono-lower alkylamino group (e.g., Mechiruamino, Echiruamino, such mode no one 6 alkylamino groups such as propyl amino), (iii) di - lower alkylamino group (eg, Jimechiruamino, di- such Jechiruamino - _ 6 alkylamino group, etc.), (iv) a 5- to 7-membered cyclic amino group which may have 1 to 3 heteroatoms selected from nitrogen, oxygen, sulfur and the like in addition to one nitrogen atom (for example, pyrrolidino, piperidino, Piperazino, morpholino, thiomorpholino, etc.); Propionyl Rua amino, such as C one 6 alkyl Ichiriki Ruponiruamin
- Examples of the condensation of the “phenyl group” of the “a phenyl group which may be condensed, and the phenyl group may have a substituent” include, for example,
- ring A represents a benzene ring which may have a substituent
- ring B represents a heterocyclic ring which may have a substituent. And the like.
- substituent on the ring A examples include the above-mentioned “substituent” in the above-mentioned “optionally condensed phenyl group, and the phenyl group may have a substituent".
- the number is one to three.
- a 14-membered (preferably 5- to 9-membered) aromatic or non-aromatic heterocyclic ring is exemplified.
- examples thereof include azine, tetrahydroxazepine, morpholine, thiomorpholine, pyrrol, pyrazole, 1,2,3-triazole, oxazole, oxazolidine, thiazol, thiazolidine, isoxazol, and imidazoline.
- a 5- to 9-membered non-aromatic heterocyclic ring containing one hetero atom or two identical or different hetero atoms eg, pyrrolidine, piperidine, hexamethyleneimine, Methyleneimine, tetrahydrofuran, piperazine, homopirazine, tetrahydrooxazepine, morpholine, thiomorpholine and the like.
- Non-aromatic heterocycles containing one heteroatom selected from atoms are preferred.
- Examples of the “substituent” of the “heterocyclic ring optionally having substituent (s)” represented by ring B include (i) a halogen atom (eg, fluoro, chloro, bromo, eodo, etc.), and ( ⁇ ) a nitro group (Iii) cyano group, (iv) oxo group, (V) hydroxy group, (vi) Lower alkyl group (e.g., methyl, Echiru, propyl, isopropyl, heptyl, Isopuchiru, t er t - heptyl, etc.
- a halogen atom eg, fluoro, chloro, bromo, eodo, etc.
- a nitro group e.g., fluoro, chloro, bromo, eodo, etc.
- a nitro group e.g., fluoro, chloro, bromo,
- d _ 6 alkyl groups such as sec- butyl
- lower alkoxy e.g., methoxy, ethoxy, Puropiruokishi, isopropyl Okishi, such Buchiruokishi - 6 alkoxy group, etc.
- lower alkylthio O group e.g., methylthio, Echiruchio, etc.
- Okiso group lower alk kill group (e.g., methyl, Echiru, propyl, isopropyl, heptyl, isobutanol chill, tert- heptyl, _ 6 alkyl groups such as sec- butyl) and the like are preferable.
- Special And an oxo group e.g., methyl, Echiru, propyl, isopropyl, heptyl, isobutanol chill, tert- heptyl, _ 6 alkyl groups such as sec- butyl
- ring B has a nitrogen atom in the ring, for example, ring B has the formula
- R 1 represents a hydrogen atom, a hydrocarbon group which may have a substituent, an acyl group or a heterocyclic group which may have a substituent. ] It may have the group represented by these. Further, ring B may have 1 to 3 of the above substituents (i) to (xxi).
- the ⁇ hydrocarbon group '' of the ⁇ hydrocarbon group which may have a substituent '' represented by R 1 represents a group obtained by removing one hydrogen atom from a hydrocarbon compound.
- an alkyl group e.g., methyl, Echiru, propyl, isopropyl, heptyl, isobutyl, tert- butyl, sec - butyl, pentyl, the hexyl, etc. - 6 Al Kill group
- alkenyl group e.g., Biel, Ariru, isoproterenol base alkenyl, butenyl, I Sobuparu, etc.
- C 2 _ 6 alkenyl group such as sec- butenyl
- an alkynyl group e.g., propargyl, Edjiniru, heptynyl, 1 one to C 2 _ 6 alkynyl groups such as carboxymethyl sulfonyl, etc.
- a cycloalkyl group e.g., cyclopropyl, cyclobutyl, Shikuropen chill, C 3 _ 6 cycloalkyl group cyclohexyl, etc. cyclohexylene, etc.
- aryl group for example, C 6 _ x 4 aryl group such as phenyl, 1-naphthyl, 2-naphthyl, biphenyl, 2-indenyl, 2-anthryl and the like, preferably phenyl group and the like)
- Ararukiru group e.g., benzyl, Fueniruechiru, phenylpropyl, phenylbutyl, phenylene Rupenchiru, phenylene Lou _ 1 of hexyl, etc., to phenyl 0 alkyl; Fei - Nafuchiru of naphthylmethyl C, one 6 alkyl; Jifue methylpropenylmethyl, C etc. Jifue two Roux E _ 3 alkyl, such as Jifueniruechiru 7 - i 6 ⁇ aralkyl group)
- Ararukiru group e.g., benzyl, Fueniruechiru, phenylpropyl, phenylbutyl, phenylene Rupenchiru, phenylene Lou _ 1 of hexyl, etc., to phenyl 0 alkyl; Fei - Nafuchiru of nap
- Ariru one alkenyl group e.g. styryl, cinnamyl, 4 one phenyl - 2-butenyl, 4 one phenyl - 3 - phenylene Lou C 2 butenyl etc. - C 6, such as x 2 alkenyl Le - x 4 ⁇ Li - Roux C 2 _ 12 alkenyl group, etc.
- Cycloalkyl-alkyl groups eg, cyclopropylmethyl, cyclobutylmethyl, cyclopentylmethyl, cyclohexylmethyl, cycloheptylmethyl, cyclopropylethyl, cyclobutylethyl, cyclopentylethyl, cyclohexylethyl, cyclo Heptylethyl, cyclopropylpropyl, cyclobutylpropyl, cyclopentylpropyl, cyclohexylpropyl, cycloheptylpropyl, cyclopropylbutyl, cyclobutylbutyl, cyclopentylbutyl, cyclohexylbutyl, cycloheptylbutyl, cyclopropylpyrpentyl, cyclo Butylpentyl, cyclopentylpentyl, cyclohexylbut
- One-way reel—C i _ 1 One-way reel—C i _ 1 .
- Alkyl group for example, biphenylmethyl, biphenylethyl, etc.
- R 1 in the "optionally substituted hydrocarbon group" of the "hydrocarbon group” preferably include, for example, - 6 alkyl group, C 3 _ 6 cycloalkyl Le group, C 7 - 6 And an aralkyl group. More preferably C 7 _! .
- Aralkyl groups eg, benzyl, phenylethyl, phenylpropyl, etc.
- Examples of the “substituent” of the “hydrocarbon group which may have a substituent” represented by R 1 include (i) a halogen atom (for example, fluoro, chloro, bromo, ), (Ii) a nitro group, (iii) a cyano group, (iv) an oxo group, (V) a hydroxy group, (vi) a lower alkyl group which may be halogenated, and (vi i) a halogenated group.
- aralkyl groups eg, benzyl, etc.
- (XXV ii) ureido groups which may have a substituent (eg, perylene, 3-methylureido, 3-ethylureido, 3-phenylureido, 3- (4-1) Fluorophenyl) ureide, 3- (2-methylphenyl) ureide, 3- (4-methoxyphenyl) ureide, 3- (2,4-difluorophenyl) ureide, 3- [3,5-bis (trifluoromethyl) Phenyl] ureido, • 3-benzylureido, 3- (1-naphthyl) ureido, 3- (2-biphenylyl) peridode, etc.), (xxviii) a thioperido group which may have a substituent (for example, Thioulide, 3-methylthioureido, 3-ethylthioureido, 3-
- Nocarponyl groups for example, pyrrolidino-carponyl, piperidinocarponyl, (4-methylpiperidino) carbonyl, (4-phenylpiperidino) carponyl, (4-benzylpiperidino) carponil, G) Power luponyl, [4 -— (4-fluorobenzoyl) piperidino] power luponyl, (4-methylpiperazino) carbonyl, (4-phenylpiperazino) power luponii , [4- (4-nitrophenyl) piperazino] -capillon, (4-benzylpiperazino) -capillon, morpholino-capillon, thiomorpholino-carbonyl, etc.), (xxxii) aminothio-caprolponyl optionally having a substituent Group (for example, aminothiocarbonyl, methylaminothiocarbonyl, dimethylaminothiocarbonyl, etc.
- halogen atom an alkyl group which may be halogenated, an alkoxy group which may be halogenated, a hydroxy group, a nitro group, a cyano group, a carboxy group, and a J- 6 alkoxy monopropionyl are preferable.
- heterocyclic group in the above “heterocyclic group optionally having substituent (s)” include, for example, For example, a 5- to 14-membered (monocyclic or 2- to 4-cyclic) heterocyclic ring containing 1 to 6 (preferably 1 to 4) heteroatoms selected from a nitrogen atom, an oxygen atom and a sulfur atom A group or the like formed by removing one is used.
- Monocyclic heterocyclic groups include pyridine, pyrazine, pyrimidine, imidazole, furan, thiophene, dihydropyridine, diazepine, oxazepine, pyrrolidine, piperidine, hexamethyleneimine, heptamethyleneimine, tetrahydrofuran, Piperazine, homopirazine, tetrahydrooxazepine, morpholine, thiomorpholine, pyrrole, pyrazole, 1,2,3-triazole, oxazol, oxazolidine, thiazol, thiazolidine, isoxazole, imidazoline And a group formed by removing one hydrogen atom from a monocyclic heterocycle such as triazolyl, thiadiazole, oxadiazol, oxathiadiazol, triazine, tetrazole and the like.
- bicyclic heterocycle examples include, for example, indole, dihydroindole, isoindole, dihydroisoindole, benzofuran, dihydrobenzofuran, benzimidazole, benzoxazole, benzisoxazole, benzothiazole, indazole , Quinoline, tetrahydroquinoline, isoquinoline, tetrahydroisoquinoline, tetrahydro-1H-tobenzazepine, tetrahydro-1H-2-benzazepine, tetrahydro-1H-3-benzazepine, tetrahydrobenzoxazepine, quinazoline, tetrahydroquinazoline, quinhydroline Groups that can remove one hydrogen atom from a bicyclic heterocycle such as quinoxaline, benzodioxane, benzodioxol, benzothiazine, and imidazopyr
- a hydrogen atom is removed from a tri- or tetra-cyclic heterocyclic ring such as acridine, tetrahydroacridine, quinoline pyro-open, indole pyro-cycloindole, isoindolo-benzazepine, etc. And the like.
- heterocyclic group is preferably a group formed by removing one hydrogen atom from a monocyclic or bicyclic heterocyclic ring.
- acyl group represented by R 1 examples include a compound represented by the formula:
- R 2 and R 3 are each (i) a hydrogen atom, and (ii) a hydrocarbon group which may have a substituent. Or (iii) represents a heterocyclic group which may have a substituent, or R 2 and R 3 are bonded to each other to form a nitrogen-containing ring group which may have a substituent together with an adjacent nitrogen atom. It may be formed. And the like.
- heterocyclic group which may have a location substituent is the "substituent group represented by R 1 And the same as the "hydrocarbon group which may be possessed” and the "heterocyclic group which may be substituted".
- ⁇ nitrogen-containing ring group optionally having substituent (s) '' formed by R 2 and R 3 , in addition to a carbon atom and one nitrogen atom, for example, selected from a nitrogen atom, an oxygen atom and a sulfur atom And a 5- to 9-membered (preferably 5- to 7-membered) nitrogen-containing saturated heterocyclic group which may contain 1 to 3 heteroatoms. More specifically, for example, the expression
- R 2 and R 3 preferably, (i) a hydrogen atom, ( ⁇ ) may be halogenated - 6 alkyl, (iii) C x _ 6 alkyl and _ 6 substituents selected from alkoxy May have 1 to 3 C 6- iQ aryl, (iii) C 7 _! 6 aralkyl (eg, benzyl, etc.); and (iv) 5- or 6-membered complex ring group (eg, pyridyl, phenyl, fenyl, etc.).
- acyl group represented by R 1 , preferably, formyl, an optionally halogenated- 6- alkyl monopropionyl (eg, acetyl, trifluoroacetyl, propionyl, etc.), 5- or 6-membered heterocyclic carbonyl ( For example, pyridylcarbonyl, chenylcarbonyl, furylcarbonyl, etc., C6-14aryu-rucarponyl (eg, benzoyl, 1-naphthoyl, 21-naphthoyl, etc.), C7-16aralkyl-carbonyl (eg, fenylacetyl) , 3-phenyl porion, etc.), C 6 _! Arylsulfonyl (eg, benzenesulfonyl, naphthylsulfonyl, etc.) and the like.
- an optionally halogenated- 6- alkyl monopropionyl eg,
- R 1 is preferably a hydrogen atom, C x _ 6 alkyl, - an E 4 Ariru Ichiriki Ruponiru etc. - 6 alkyl one local Poniru, C 6.
- Benzoxazines such as 3-benzoxazine, 3,4-dihydro 2 H-3,1-benzoxazine; 3,4-dihydro-1H-2,1-benzothiazine;
- Benzodiazines such as 4-tetrahydroquinazoline and 1,2,3,4-tetrahydroquinoxaline; 3,4-dihydro-1,2-benzoxathiin, 3,4 dihydro-2,1-benzoxathiin, 2,3-dihydro— 1,4-I-benzoxatiin, 1,4-dihydro-2,3-benzoxatiin, 4H-1, Benzoxatiin such as 3-benzoxatiin, 4H-3,1-benzoxatiin; 3,4-dihydro-1,2_benzodioxin, 2,3-dihydro — 1,4-benzodioxin, 1,4-dihydro-2,3— Benzodioxins such as benzodioxin and 4H-1,3-benzodioxin; 3,4 dihydro-1,2-benzdithiin, 2,3-dihydro-1,4-benzdithiin, 1,4 dihydro-2,3-benzdi
- Benzodioxepins such as 4-benzodioxepin; 4,5-dihydro-1H-2,3-benzophenepin, 1,5-dihydro-2,4-benzodichepin, 3,4-dihydro-2H — 1,5-benzodichepine, 2,3-dihydro-5H—1,4-benzodichepine, such as benzodichepine, 3,4,5,6-tetrahydro 2H—1,5-benzoxazosin, 3,4,5 Benzoxazosin, such as 2,6-tetrahydro-2H-1,6-benzoxazosin; 3,4,5,6-tetrahydro-1 2H-1,5-benzothiazosin, 3,4,5,6-tetrahydro- Benzothiazosin such as 2H-1,6-benzothiazosin; benzodiazosin such as 1,2,3, -4,5,6-hexahydro-1,6-benzodiazosin; 2,
- the ring B ' is a 5- to 9-membered nitrogen-containing heterocyclic ring which may have a substituent, and the other descriptions are as defined above. And the like.
- Examples of the “5- to 9-membered nitrogen-containing heterocyclic ring” of the “optionally substituted 5- to 9-membered nitrogen-containing heterocyclic ring” include, in addition to a carbon atom and one nitrogen atom, for example, nitrogen A 5- to 9-membered nitrogen-containing heterocyclic ring which may contain 1 to 3 heteroatoms selected from an atom, an oxygen atom and a sulfur atom, and a 5- to 9-membered non-aromatic nitrogen-containing heterocyclic ring ( For example, pyrrolidine, piperidine, hexamethyleneimine, heptamethyleneimine, piperazine, homopirazine, tetrahydrooxazepine, morpholine, thiomorpholine and the like are preferably used.
- the “5- to 9-membered nitrogen-containing heterocyclic ring” of the “optionally substituted 5- to 9-membered nitrogen-containing heterocyclic ring” include, in addition to a carbon atom
- substituted heterocyclic ring examples include one to three substituents selected from the same as the “substituent” of the “optionally substituted heterocyclic ring” represented by ring B above. Is preferably oxo.
- ring Ba represents a heterocyclic ring which may have a substituent, and the other symbols have the same meanings as described above. And the like. Particularly preferably, the formula
- the “substituent” of the “optionally substituted heterocyclic ring” represented by ring Ba the “substituted” of the “optionally substituted heterocyclic ring” represented by the above ring B
- substituents include 1 to 3 substituents selected from the same groups as those described above, and oxo is preferred.
- Specific examples of the case of condensing with or condensing with two identical or different monocyclic rings include:
- ring A is as defined above, one of ring C and ring D is a heterocyclic ring which may have a substituent, and the other is a 5- to 9-membered ring which may have a substituent . And the like.
- heterocycle of the “heterocycle optionally having substituent (s)” represented by ring C or D
- heterocycle optionally having substituent (s) shown by ring B
- the “5- to 9-membered ring” of the “5- to 9-membered ring which may have a substituent” represented by the ring C or D is a hetero atom selected from a nitrogen atom, an oxygen atom and a sulfur atom.
- Or three may be contained, for example, a 5- to 9-membered heterocyclic ring (for example, Pyridine, pyrazine, pyrimidine, imidazole, furan, thiophene, dihydropyridine, diazepine, oxazepine, pyrrolidine, piperidine, hexamethyleneimine, heptamethyleneimine, tetrahydrofuran, piperazine, homopyrazine, tetrahydrooxazepine, Morpholine, thiomorpholine, etc.),
- a 5- to 9-membered heterocyclic ring for example, Pyridine, pyrazine, pyrimidine, imidazole, furan, thiophene, dihydropyridine, diazepine, oxazepine, pyrrolidine, piperidine, hexamethyleneimine, heptamethyleneimine, tetrahydrofuran, piperazine, homo
- 5- to 9-membered carbon rings for example, benzene, cyclopentane, cyclopentene, cyclohexane, cyclohexene, cyclohexene, cycloheptane, cycloheptene, cycloheptadiene, etc.
- a 5- to 7-membered ring is preferred.
- benzene, cyclohexane and the like are preferable.
- the ⁇ substituent '' of the ⁇ 5- to 9-membered ring which may have a substituent '' is the same as the ⁇ substituent '' of the ⁇ heterocyclic ring which may have a substituent '' represented by the ring B. The thing is mentioned.
- the C ′ ring and the D ′ ring each have a 5- to 9-membered nitrogen-containing heterocyclic ring which may have a substituent, and the other descriptions have the same meanings as described above. And the like are preferred.
- the “optionally substituted 5- to 9-membered nitrogen-containing heterocyclic ring” represented by the ring C ′ or the ring D ′ includes the “optionally substituted 5- to 5-membered heterocyclic ring” represented by the ring B ′.
- the same ones as in the "9-membered nitrogen-containing heterocycle” can be mentioned.
- an oxo group is preferable.
- the C ′′ ring and the D ′′ ring each represent a nitrogen-containing heterocyclic ring which may have a substituent, and the other description is as defined above.
- the group etc. which are represented by these are mentioned.
- a phenyl group which may be condensed wherein the phenyl group may be substituted, and the phenyl group may be substituted;
- ring ⁇ is as defined above, at least one of ring E, ring F and ring G is a heterocyclic ring which may have a substituent, and the other rings may have a substituent.
- the "optionally substituted heterocyclic ring” and the “optionally substituted 5- to 9-membered ring” represented by ring E, ring F or ring G are ring B or ring C And "a 5- or 9-membered ring which may have a substituent", respectively.
- ring E ', ring F' and ring G 'each may have a 5- or 9-membered nitrogen-containing heterocyclic ring which may have a substituent,-is a single bond or a double bond, Other descriptions have the same significance as above.
- the “optionally substituted 5- to 9-membered nitrogen-containing heterocycle” represented by ring E ′, F ′ and G ′ is referred to as ⁇ having a substituent represented by ring B ′ And 5 to 9-membered nitrogen-containing heterocycles ”.
- a substituent represented by ring B ′ And 5 to 9-membered nitrogen-containing heterocycles As the substituent, an oxo group Is preferred.
- each S has the same meaning as described above.
- each symbol has the same meaning as described above.
- Ar is preferably a phenyl group which may be condensed, and the phenyl group may have a substituent.
- n is preferably an integer from 1 to 6. More preferably, it is 2 to 6. Particularly preferably, it is 2.
- halogen atom represented by R and R ′ include fluorine, chlorine, bromine, iodine and the like, with fluorine being preferred.
- Examples of the “optionally substituted hydrocarbon group” represented by R and R include the same as the “optionally substituted hydrocarbon group” represented by R 1 .
- R and R are preferably a hydrogen atom or fluorine.
- R and R ' are more preferably hydrogen atoms.
- R 4 and R 5 each represent a nitrogen atom, a hydrocarbon group which may have a substituent, or an acyl group. And the like.
- the “optionally substituted hydrocarbon group” and “acyl group” represented by R 4 or R 5 include the “optionally substituted hydrocarbon group” represented by R 1 And the same as the “acyl group”.
- nitrogen-containing saturated heterocyclic group of the “optionally substituted nitrogen-containing saturated heterocyclic group” represented by Y, in addition to a carbon atom and one nitrogen atom, a nitrogen atom, an oxygen atom and Examples thereof include a 5- to 9-membered (preferably 5- to 7-membered) nitrogen-containing saturated heterocyclic group which may contain 1 to 3 heteroatoms selected from sulfur atoms.
- the “substituent” of the “nitrogen-containing saturated heterocyclic group optionally having substituent (s)” the “substituent” of the “heterocyclic ring optionally having substituent (s)” represented by ring B above And the number of the substituents is 1 to 5.
- the nitrogen in the “nitrogen-containing saturated heterocyclic group” of the “nitrogen-containing saturated heterocyclic group optionally having substituent (s)” has the same group as the group represented by R 1 above. Is also good.
- R 6 has the same meaning as R 1 . And the like. More preferably, the formula
- R 6 is as defined above. And the like.
- R 6 is preferably a hydrogen atom or a hydrocarbon group which may have a substituent. More preferably, a halogen atom (preferably Furuoro etc.), _ 6 alkyl (preferably methyl, etc.), C! _ 6 alkoxy (preferably methoxy, etc.), Shiano, nitro and, 1 to substituents selected from hydroxy optionally having three C 7 - 6 Ararukiru group (preferably benzyl), and the like.
- a halogen atom preferably Furuoro etc.
- _ 6 alkyl preferably methyl, etc.
- C! _ 6 alkoxy preferably methoxy, etc.
- Shiano nitro and, 1 to substituents selected from hydroxy optionally having three C 7 - 6 Ararukiru group (preferably benzyl), and the like.
- Ar is a compound of the formula
- the Ba ring, the C ′′ ring and the D ′′ ring each may have one or two substituents selected from C 6 alkyl, 6 alkyl monocarbonylamino and C! _ 6 alkylsulfonylamino;
- n 2;
- R and R ' are each a hydrogen atom or fluorine (more preferably a hydrogen atom);
- R 6 is (1) hydrogen atom, [23 Shiano, hydroxy, (mono- or di) C ⁇ - e T alkylamino (Jechiruamino etc.), pyridyl, and (in ⁇ _ 6 alkyl (E Ji Le etc.)) esterified C _ 6 alkyl (methyl, ethyl, isopropyl, etc.) which may have a substituent selected from carboxy which may be used, [3] halogen (fluoro, chloro mouth, etc.), _ 6 alkyl (methyl, t one heptyl, etc.), halogeno ⁇ - 6 alkyl (triflate Ruo b methyl, etc.), hydroxy, C _ 6 ⁇ alkoxy (methoxy, etc.), nitro, Amino, Shiano force Rubamoiru, with (Ci _ 6 'alkyl, etc.) ester reduction is optionally substituted with even better carboxy optionally have good _ 6 alk
- Ar is a compound of the formula
- n 2;
- R and R ' are each a hydrogen atom or fluorine (more preferably a hydrogen atom) That is,
- R 6 represents a benzyl which may have one or two substituents selected from a halogen atom, —3 alkyl, di- 3 alkoxy, cyano, nitro and hydroxy. And the like.
- the compounds of Reference Examples 1 to 30 described in WO 00/18391 or salts thereof are used.
- Ar 2 represents a 5- or 6-membered aromatic ring group which may be condensed, the aromatic ring group may have a substituent, and L is a main group which may have a substituent. or to 1 -C chain showing the 10 scan Bae one server, or a between r 2 in may form a ring, Y 2 is an optionally substituted amino group or a substituted group And a nitrogen-containing heterocyclic ring which may have (Hereinafter abbreviated as compound (II))
- examples of the “substituent” of “a 5- or 6-membered aromatic ring group which may be condensed, and the aromatic ring group may have a substituent” represented by Ar 2 include: For example, (i) a lower alkyl group which may be halogenated, (ii) a halogen atom (for example, fluoro, chloro, bromo, eodo, etc.), (iii) a lower alkylenedioxy group (for example, methylenedioxy, ethylenedioxy and the like) C, _ 3 Arukirenjio alkoxy group), (iv) a nitro group, (V) Shiano group, (vi) hydroxy group, (vii) optionally halogenated substituted lower alkoxy group, (vii i) a cycloalkyl group ( for example, cyclopropyl, cyclobutyl, cyclopentyl, C 3- 6 cycloalkyl group cyclohexy
- C WINCH such Jechiruamino 6 Alkylamino group (xiii) 5- to 7-membered cyclic amino group (for example, having 1 to 3 heteroatoms selected from nitrogen, oxygen and sulfur atoms in addition to one nitrogen atom) A 5- to 7-membered cyclic amino group (eg, topyrrolidinyl, piperidino, topiperazinyl, morpholino, thiomorpholino, etc.), etc.), (xiv) lower alkyl monofunctional luponylamino group (eg, acetylamino, propionylamino, butyrylamino, etc.) of C, _ 6 alkyl one force Ruponiruami Amino group etc.), (xv) lower alkylsulfonyl ⁇ amino group (e.g., Mechirusuruhoni Ruamino, E chill sulfonyl ⁇ amino, C Les 6 Al Kill sulfony
- _ 6 alkyl Ichiriki Ruponiru group such Puchirukaruponiru
- (xix) cycloalkyl Ichiriki Ruponiru group e.g., cyclopropyl force Ruponiru, cycloalkyl Puchirukaruponiru, cyclopentyl Luca Lupo sulfonyl, C 3 _ 6 a cycloalkyl of Kishirukaruponiru such as cyclohexane (XX) carbamoyl group, thiocarbamoyl group, (xxi) mono-lower alkyl monofunctional rubamoyl group (for example, methyl-carbamoyl, ethyl carbamoyl, propyl carbamoyl, butyl carbamoyl, etc.) , _ 6 alkyl Ichiriki Rubamoiru group), (xxi i) di-lower alkyl Ichiriki Rub
- diphenyl C ⁇ 6 alkyl group such as diphenylmethyl, diphenylethyl, etc.
- XX ix mono-phenyl lower al
- phenylene Lou lower alkylamino group e.g., phenylene Rumechiruamino, phenyl, such as phenylene Ruechiruamino - C Bok 6 alkylamino group, etc.
- phenylene Lou lower alkylsulfonyl group for example, phenylene Lou methylsulfonyl, phenylene Lou E chill sulfonyl or the like phenyl -.
- C, fi al (Xxxxix) 5- to 7-membered cyclic amino-sulfonyl group (for example, having one to three heteroatoms selected from nitrogen, oxygen and sulfur atoms in addition to one nitrogen atom) 5 may be 5- to 7-membered cyclic amino one sulfonyl group (e.g., (1-pyrrolidinyl) sulfonyl, peak Beri Gino sulfonyl, alpha-piperazinyl) sulfonyl, morpholinosulfonyl, etc.
- one sulfonyl group e.g., (1-pyrrolidinyl) sulfonyl, peak Beri Gino sulfonyl, alpha-piperazinyl
- pentyl,, _ 6 alkyl, etc. lower alkoxy (e.g., methoxy, ethoxy Alkoxy, propoxy, isopropoxy, butoxy, isobutoxy, sec- butoxy, tert C Les 6 alkoxy butoxy, etc.), a halogen atom (e.g., chlorine, blanking ROM, ® one de, etc.), hydroxy group, Benjiruokishi group, amino group, mono - lower alkylamino group (e.g., Mechiruamino, Echiruamino, mono- C such propylamino, _ 6 alkylamino, etc.), di-lower alkylamino group (e.g., dimethyl Chiruamino, di etc.
- lower alkoxy e.g., methoxy, ethoxy Alkoxy, propoxy, isopropoxy, butoxy, isobutoxy, sec- butoxy, tert C Les 6 alkoxy butoxy,
- Jechiruamino -. C 6 alkyl 1 to 4 substituents selected from amino, etc.), a nitro group, a lower alkyl-carbonyl group (e.g., methyl 6- alkyl-carbonyl such as methyl carbonyl, ethyl carbyl, butyl carbonyl, etc.), a benzoyl group and the like. You may have. ) And the like.
- the ⁇ optionally condensed 5- or 6-membered aromatic ring group '' represented by Ar may have 1 to 4, preferably 1 or 2 of these (i) to (xxxxxi ii) substituents. Good.
- optionally lower alkyl group examples include, for example, a lower alkyl group which may have 1 to 3 halogen atoms (for example, chloro, bromo, and the like) (for example, , methyl, Echiru, propyl, isopropyl, butyl, sec- butyl, tert- butyl, pentyl, C of hexyl, etc.,.
- halogen atoms for example, chloro, bromo, and the like
- halogen atoms for example, chloro, bromo, and the like
- 6 alkyl Le group and the like to, and specific examples include methyl, chloromethyl, Difluoromethyl, trichloromethyl, trifluoromethyl, ethyl, 2-promoethyl, 2,2,2-trifluoroethyl, propyl, 3,3,3-trifluoropropyl, isopropyl, butyl, 4,4,4-trifluoro O-butyl, iso-butyl, sec-butyl, tert-butyl, pentyl, isopentyl, neopentyl, 5,5,5-trifluoropentyl Hexyl, 6, 6, hexyl, and the like to 6 Torifuruo port.
- halogenated lower alkoxy group examples include, for example, a lower alkoxy group which may have 1 to 3 halogen atoms (for example, chloro, bromo, and the like) (for example, Methoxy, ethoxy, propoxy, isopropoxy, butoxy, isobutoxy, sec-butoxy, tert-butoxy and other C alkoxy groups).
- halogen atoms for example, chloro, bromo, and the like
- Examples of the “optionally lower halogenated lower alkylthio group” include, for example, a lower alkylthio group optionally having 1 to 3 halogen atoms (for example, chloro, bromo, and the like); for example, methylthio, Echiruchio, pro Piruchio, isopropylthio, butylthio, isobutylthio, sec- butylthio, etc. C!
- _ 6 alkylthio groups such as ter t-Puchiruchio) and the like, and specific examples include methylthio, Jifuruoro Examples include methylthio, trifluoromethylthio, ethylthio, propylthio, isopropylthio, butylthio, 4,4,4-trifluorob'tylthio, isobutylthio, sec-butylthio, tert-butylthio, pentylthio, and hexylthio.
- the “substituent” in “showing a 5- or 6-membered aromatic ring group which may be condensed, and the aromatic ring group may have a substituent” is preferably (i) an amino group, (ii) model no lower alkylamino group (e.g., Mechiruamino, Echiruamino, mono- and propyl amino - like C Bok 6 alkylamino group), (iii) Gee lower alkylamino amino group (e.g., Jimechiruamino, such Jechiruamino di - C, _ 6 An alkylamino group, etc.), (iv) a 5- to 7-membered cyclic amino group which may have, in addition to one nitrogen atom, one to three heteroatoms selected from nitrogen, oxygen and sulfur, etc.
- model no lower alkylamino group e.g., Mechiruamino, Echiruamino, mono- and propyl amino - like C Bok 6
- phenylene Lou lower alkyl amino e.g., Hue sulfonyl - Mechiruamino, phenylene Lou C such as phenylene Ruechiruamino, _ 6 alkylamino, etc.
- Hue two Lou lower alkylsulfonylamino group e.g., phenylene Lou methylsulfonyl ⁇ amino, such as phenyl one C Bok 6 alkyl one Suruhoniruamino group such as phenylene Ruechirusu Ruhoniruamino
- ix 9486
- Phenylsulfonylamino group (X) halogen atom (for example, fluoro, chloro, etc.), (xi) lower alkyl group which may be halogenated (for example, methyl, ethyl, isopropyl, tert-butyl, trifluoro) Methyl, etc.), (xi i) optionally substituted lower alkoxy group (for example, methoxy, ethoxy, isopropoxy, tert-butoxy, trifluoromethoxy, etc.), (xi ii) aminosulfonyl group, (xiv ) mono- lower alkylaminosulfonyl group (e.g., methylaminosulfonyl, E chill aminosulfonyl, propyl aminosulfonyl, such as blanking chill aminosulfonyl mono -.
- halogen atom for example, fluoro, chloro, etc.
- mono-lower alkyl monofunctional rubamoyl group for example, mono-C ⁇ 6 alkyl-carbamoyl group such as methylcarbamoyl, ethylcarbamoyl, propyl-powered rubamoyl, butylcarbamoyl, etc.
- Gee lower alkyl Ichiriki Rubamoiru group e.g., Jeffrey Ji carbamoyl, di one C such Jibuchirukaruba moil, _ 6 alkyl Ichiriki Rubamoiru group
- di-lower alkylamino group e.g., Jimechiruamino, Jechiruamino like di - C, _ 6 alkylamino group, etc.
- one nitrogen atom other than the nitrogen atom, to 5 which may have 1 to 3 heteroatoms selected from oxygen atom and sulfur atom, such as 7 Member cyclic amino group (eg, 1-pyr
- aminosulfonyl group aminosulfonyl group, mono-lower alkylaminosulfonyl group (for example, methylaminosulfonyl, ethylaminosulfonyl, propylaminosulfonyl, butylaminosulfonyl, C Medicine 6 alkyl ⁇ amino sul Honiru group), di - - mono equal lower alkyl primary amino sulfonyl group (e.g., Jechirua Minosuruhoniru, dibutyl Rua amino sulfo El like G C Bok 6 alkylamino sul Honiru groups, force Rubamoiru groups, mono- lower alkyl Ichiriki Rubamoiru group (e.g., methylcarbamoyl, E Ji carbamoyl, propyl force Rubamoiru, mono-
- the "5 or 6-membered aromatic ring group” in the “condensed may be 5 or 6-membered aromatic ring group” represented by A r 2, phenyl group (a benzene ring group), a 5- or 6-membered aromatic heterocyclic And a ring group.
- the “5- or 6-membered aromatic heterocyclic group” includes, for example, 5 or 6 containing, in addition to carbon atoms, one or more (for example, 1 to 3) heteroatoms selected from nitrogen, sulfur and oxygen. And a membered aromatic heterocyclic group. Specifically, phenyl, furyl, pyrrolyl, imidazolyl, pyrazolyl, thiazolyl, isothiazolyl, oxazolyl, isoxazolyl, pyridyl, pyrazinyl, pyrimidyl
- a r 2 of the "fused optionally may 5 or 6-membered aromatic ring group optionally” in the “5 or 6-membered aromatic ring group” is, for example, “optionally substituted phenyl group”
- condensation of the “phenyl group” include, for example,
- the phenyl group described in the above “(a)“ A phenyl group which may be condensed, and the phenyl group may have a substituent ” is condensed with a monocyclic homocyclic ring or a heterocyclic ring.
- a The bicyclic substituent, the above A r 2 '5 may be fused shown until Or a 6-membered aromatic ring group, and the like, and the number of the substituents is 1 to 3.
- B 2 ring of the "optionally substituted homocyclic rings" as “homocyclic” is 5 to 9-membered carbocyclic ring (e.g., cyclohexane, benzene, cyclopentane, cyclopent down, cyclohexane, Cyclohexene, cyclohexadiene, cycloheptane, cycloheptene, cycloheptadiene, etc.).
- carbocyclic ring e.g., cyclohexane, benzene, cyclopentane, cyclopent down, cyclohexane, Cyclohexene, cyclohexadiene, cycloheptane, cycloheptene, cycloheptadiene, etc.
- heterocycle of “optionally substituted heterocyclic ring” represented by B 2 rings, for example, nitrogen atom, for 4 to contain 1 to 4 hetero atoms selected from oxygen atom and a sulfur atom
- Examples include diazolidine, thiadiazinane, isoxazole, imidazoline, imidazolidine, hexahydropyrimidine and the like.
- a 5- to 9-membered non-aromatic heterocycle containing one hetero atom or two identical or different hetero atoms eg, pyrrolidine, piperidine, hexamethyleneimine, heptaimine
- Methyleneimine tetrahydrofuran, tetrahydropyran, 1,4-dioxane, piperazine, homopiperazine, tetrahydrooxazepine, morpholine, thiomorpholine, imidazoline, thiadiazolidine, thiadiadinane, imidazolidine, hexahydropyrimidine Etc.
- a non-aromatic heterocycle containing one hetero atom selected from, for example, a nitrogen atom, an oxygen atom and a sulfur atom (2) one nitrogen atom and a nitrogen atom, an oxygen atom and a sulfur atom
- Non-aromatic heterocycles containing one heteroatom selected from atoms are preferred.
- Examples of the "substituent" represented by the "homocyclic ring may be substituted or a heterocyclic" 2 rings, e.g., (i) a halogen atom (e.g., Furuoro, chlorine, bromine, (U) nitro group, (iii) cyano group, (iv) oxo group, (V) hydroxy group, (vi) lower alkyl group (for example, methyl, ethyl, propyl, isopropyl, butyl, isobutyl , tert- butyl, C WINCH 6 alkyl group or the like) (vii) a lower alkoxy group such as sec- butyl (for example, methoxy, ethoxy, Puropiruoki shea, isopropyl O alkoxy, such as C 6 alkoxy group such as Buchiruokishi), (viii) lower alkylthio (e.g., methylthio, Echiruch
- lower alkylaminosulfonyl group e.g., dimethylamino sulfonyl, di C 6 alkyl primary amino sulfonyl group such Jechiruaminosu Ruhoniru etc.
- Okiso group a lower alkyl group (e.g., methyl, Echiru, propyl, isopropyl, butyl, isobutyl, tert- butyl, sec - C of the probe chill etc., _ 6 alkyl group or the like) and the like are preferable.
- the ring B 2 has a nitrogen atom in the ring, for example, the ring B 2 has the formula
- R 7 represents a hydrogen atom, a hydrocarbon group which may have a substituent, an acyl group or a heterocyclic group which may have a substituent. ] It may have the group represented by these. Further, B 2 ring may have 3 to 1 to not above substituents (i) to (xxiv).
- the ⁇ hydrocarbon group '' of the ⁇ hydrocarbon group which may have a substituent '' represented by R 7 represents a group obtained by removing one hydrogen atom from a hydrocarbon compound.
- C, etc. _ 16 hydrocarbon group is a group obtained by removing one hydrogen atom from a hydrocarbon compound.
- an alkyl group e.g., methyl, Echiru, propyl, isopropyl, heptyl, isobutyl, tert- butyl, sec- butyl, C of hexyl etc. pentyl,,. 6 alkyl Le group
- alkenyl e.g., vinyl, Ariru, isoproterenol base alkenyl, butenyl, I Sobuparu, etc.
- alkenyl group such as sec- butenyl
- an alkynyl group e.g., propargyl, Echeru, heptynyl, 1 one to carboxymethyl sulfonyl, etc. C 2 - 6 alkynyl group
- a cycloalkyl group e.g., cyclopropyl, cyclobutyl, Shikuropen chill, C 3 of cyclohexyl etc. cyclohexane - 6 cycloalkyl group
- Bridged cyclic lower saturated hydrocarbon group for example, bicyclo [3.2.1] One I Le, bicyclo [3.3.1] non one 2-I le, Adamantan one 1-I le like crosslinked cyclic C 8. 14 saturated hydrocarbon group
- Ariru group e.g., phenyl, 1-naphthyl, 2-naphthyl, Bifue two Le, 2-indenyl, 2-anthryl C 6 _ 14 Ariru groups such as, preferably full Weniru group)
- Ararukiru group e.g., benzyl, Fueniruechiru, phenylpropyl, phenylbutyl, phenylene Rupenchiru, phenylene Lou C _ 10 alkyl cyclohexyl, etc., to phenyl; Nafuchiru C such as ⁇ - naphthylmethyl, _ 6 alkyl;! Jifue two Rumechi Le, Jifue such Jifueniruechiru two Lou C,. C 7 3 alkyl, and the like. 16 Ararukiru group)
- Ariru - alkenyl e.g. styryl, cinnamyl, 4-phenylene Lou 2-butenyl, 4 one phenylene Lou 3- phenyl butenyl, etc. - C 2 - 12 C 6 _ 14 Ariru alkenyl such as - C 2 _ 12 alkenyl group, etc.
- Cycloalkyl monoalkyl groups eg, cyclopropylmethyl, cyclobutylmethyl, cyclopentylmethyl, cyclohexylmethyl, cycloheptylmethyl, cyclopropylethyl, cyclobutylethyl, cyclopentylethyl, cyclohexylethyl, cyclo Heptylethyl, cyclopropylpropyl, cyclobutylpropyl, cyclopentylpropyl, cyclohexylpropyl, cycloheptylpropyl, cyclopropylbutyl, cyclobutylbutyl, cyclopentylbutyl, cyclohexylbutyl, cycloheptylbutyl, cyclopropylpyrpentyl, cyclo Butylpentyl, cyclopentylpentyl, cyclohexylbut
- R 7 Represented by R 7 in "optionally substituted hydrocarbon group” as preferred "hydrocarbon group", for example, C WINCH 6 alkyl group, C 3 - 6 cycloalkyl group, C 7. And 16 aralkyl groups. More preferably C 7 _ 10 Ararukiru group (e.g., benzyl, Fueniruechiru, phenylene Lou C such as phenylpropyl,. 4 alkyl, etc.), and the like. .
- hydrocarbon group for example, C WINCH 6 alkyl group, C 3 - 6 cycloalkyl group, C 7. And 16 aralkyl groups. More preferably C 7 _ 10 Ararukiru group (e.g., benzyl, Fueniruechiru, phenylene Lou C such as phenylpropyl,. 4 alkyl, etc.), and the like. .
- Examples of the “substituent” of the “hydrocarbon group which may have a substituent” represented by R 7 include: (i) a halogen atom (for example, fluoro, chloro, bromo, sulfide, etc.), (ii) nitro group, (iii) Shiano group, (iv) Okiso group, (V) hydroxy shea group, (vi) an optionally halogenated lower (C,. 6) alkyl group, (vii) halogenated (C 6 ) alkoxy group which may be substituted, (viii) lower (C 6.
- a halogen atom for example, fluoro, chloro, bromo, sulfide, etc.
- Alkylthio group which may be halogenated, (ix) amino group, (X) mono-lower alkylamino group (for example, Mechiruamino, Echiruamino, Puropirua Mino like mono - C Bok 6 alkylamino group, etc.), (xi) di - lower alkylamino group (e.g., Jimechiruamino, G.
- a carbon atom and one nitrogen A 5- to 7-membered cyclic amino group which may have 1 to 3 heteroatoms selected from nitrogen, oxygen, sulfur and the like in addition to the atom (eg, 1-pyrrolidinyl, piperidino, topiperazinyl, morpholino, thiol morpholino), (xiii) lower alkyl Ichiriki Ruponiruamino group (e.g., Asechiruamino, propionyl Rua amino, C etc.
- C 6 10 Ariru may have a benzyl, etc.) Chioureido group (e.g., Chioureido, 3-methyl-thioureido, 3-E Ji Lucio ureido 3-phenylthioureido, 3- (4-fluorophenyl) thioureide, 3- (4-methylphenyl) thioureide, 3- (4-methoxyphenyl) thioureide, 3- (2,4-dichlorophenyl) thioureide, 3-— Benzylthioureido, 3- (1-naphthyl) Chioureido etc.), (xxix) substituent (e.g., C _ 4 Al kill, Ji, Ariru, nitro -.
- substituent e.g., C _ 4 Al kill, Ji, Ariru, nitro -.
- 1 to 2 substituents selected from C 6 _ 10 Ariru etc. have which may be an amidino group (e.g., amidino, N 1 - Mechiruamijino, N 1 - Echiruamijino, N 1 - Fueniruamijino, N 1, N 1 - dimethyl-amidino, N 1, N 2 - dimethyl-amidino, N 1 - methyl-N 1 - Echiruamijino, N 1, N Jechiruamijino, NI- methyl one N 1 - Fueniruamijino, N 1, N 1 - di (4 twelve Torofueniru) amidino, etc.), (XXX) substituent (e.g., C, _ 4 alkyl Le, (: 6 selected from aryl, nitro-C, aryl, etc .;!
- guanidino groups eg, guanidino, 3-methyldanidino, 3,3-dimethyldanidino, 3 3—Jetildani Roh, etc.
- location 'substituent for example, C, _ 4 alkyl, halogeno C _ 4 alkyl, C 6 10 Ariru, halogeno C 6 10 Ariru, C Bok 4 alkyl -!..
- Cyclic aminocarbonyl groups eg, (1-pyrrolidinyl) carbonyl, piperidino carbonyl, (4-methylpiperidino) carbonyl, (4-1 phenylbiperidino) carbonyl, (4-benzylpiperidino) G) carbonyl, (4-benzoylpiperidino) carbonyl, [4- (4-fluorobenzoyl) piperidino] -capillonil, (4-methyl-1-piperazinyl) carbonyl, (4-phenyl-1-pipidinyl) (Razinyl) diluponyl, [4- (4-1-2trophenyl) -topiperazinyl] diluponyl, (4-benzyl-1-piperazinyl) carbonyl, morpholino
- aminothiol carbonyl group eg, aminothiol carbonyl, methylaminothiocarbonyl, dimethylaminothiocarbonyl, etc.
- substituent eg, C 4 alkyl , 1 2
- aminosulfonyl group which may have a selected from C 6 _ 1Q Ariru like (e.g., aminosulfonyl, methylaminosulfonyl, dimethyl ⁇ amino sulfonyl, etc.), (xxxiv) substituent (e.g., halogen atom, C Bok alkyl, halogeno C Bok 4 alkyl, C
- phenylalanine alkylsulfonyl ⁇ have a Mino selected from (e.g., phenylalanine sulfonyl ⁇ amino, (4 Mechi Rufueniru) Suruhoniruamino, (4- Black phenyl) sulfonylamino,
- 5- to 7-membered cyclic amino-carbonyloxy group which may have 1 to 3 atoms (eg, (topyrrolidinyl) carbonyloxy, piperidinocarbonyloxy, (1-piperazinyl) , Morpholinocarbonyloxy, thiomorpholino carbonyl group, etc.) and the like.
- halogen atom optionally halogenated C,. 6 Al Kill group, an optionally halogenated C, _ 6 alkoxy group, hydroxy group, nitro port group, Shiano group, a carboxy group, C, _ 6 alkoxy Ichiriki Ruponiru group, force Rubamoi group, amino Chio carboxymethyl group, a mono - C Les 6 alkyl Ichiriki Rubamoiru group, di - C i _ 6 alkyl rubamoyl group, amino group, mono-C 6- alkylamino group, di-C 6- alkylamino group, 5- to 7-membered cyclic amino group, alkyl-type ryponylamino group, aminosulfonyl group, mono-C 6 alkylamino sulfonyl group, di one C Les 6 alkylaminosulfonyl group, phenylpropyl sulfonyl ⁇ amino group, such as C! _ 6
- heterocyclic group in the “(xxiv) heterocyclic group optionally having substituent (s)” include, for example, 1 to 6 heteroatoms selected from a nitrogen atom, an oxygen atom and a sulfur atom (preferably 5- to 14-membered (monocyclic or 2- or 4-cyclic) containing 1 to 4 groups include groups formed by removing one hydrogen atom from a heterocyclic ring.
- Monocyclic heterocyclic groups include pyridine, pyrazine, pyrimidine, imidazole,
- thiophene dihydropyridine, diazepine, oxazepine, pyrrolidine, piperidine, hexamethyleneimine, heptamethyleneimine, tetrahydrofuran, piperazine, homopidazine, tetrahydrooxazepine, morpholine, thiol Monocyclic such as morpholine, pyrrol, pyrazole, 1,2,3-triazole, oxazole, oxazolidine, thiazole, thiazolidine, isoxoxazole, imidazoline, triazole, thiadiazol, oxaziazole, oxothiadiazole, triazine, tetrazole, etc. Examples include a group formed by removing one hydrogen atom from a heterocycle.
- bicyclic heterocyclic ring examples include, for example, indole, dihydroindole, isoindole, dihydroisoindole, benzofuran, dihydrobenzofuran, benzimidazole, benzoxazole, benzisoxazole, benzothiazole, Indazole, quinoline, tetrahydroquinoline, isoquinoline, tetrahydroisoquinoline, tetrahydro-1H-tobenzazepine, tetrahydric mouth-1H-2-benzazepine, tetrahydro-1H-3-benzazepine, tetrahydrobenzoxazepine, quinazoline, tetrahydroquinazoline Groups that can remove one hydrogen atom from a bicyclic heterocycle such as quinoxaline, tetrahydroquinoxaline, benzodioxane, benzodioxol, benzothia
- Examples of the tri- or tetracyclic heterocyclic group include acridine, tetrahydroacridine, Examples include groups formed by removing one hydrogen atom from a tri- or tetracyclic heterocycle, such as loroquinoline, pyro-indole, cyclobentoindole, and isoindolobenzazepine.
- heterocyclic group a group formed by removing one hydrogen atom from a monocyclic or bicyclic heterocyclic ring and the like are preferable.
- the "substituent of the B" homocyclic ring may be substituted or a heterocyclic ring "represented by 2 ring as the" substituent "of the” optionally heterocyclic group which may have a substituent " And the number of the substituents is 1 to 5.
- acyl group represented by R 7 examples include a compound represented by the formula:
- R 8 and R 9 each represent (0 hydrogen atom, ( ⁇ ) a hydrocarbon group optionally having a substituent, or (iii) a heterocyclic group optionally having a substituent. R 8 and R 9 may combine with each other to form a nitrogen-containing ring group which may have a substituent together with an adjacent nitrogen atom.]
- hydrocarbon group which may have a substituent and the “heterocyclic group which may have a substituent” represented by R 8 or R 9 are the same as those having a substituent represented by R 7 above. Hydrocarbon group which may be substituted and heterocyclic group which may have 9486
- the ⁇ nitrogen-containing ring group which may have a substituent '' formed by R 8 and R 9 is, for example, selected from a nitrogen atom, an oxygen atom and a sulfur atom in addition to a carbon atom and one nitrogen atom.
- a 5- to 9-membered (preferably 5- to 7-membered) nitrogen-containing saturated heterocyclic group which may contain 1 to 3 heteroatoms. More specifically, for example, the expression
- the "substituent" of the "nitrogen-containing ring group optionally having substituent (s)” the “substituent” of the "homocyclic ring or heterocycle optionally having substituent (s)” for the ring B
- the number of substituents is 1 to 5.
- acyl group represented by R 7 , preferably, formyl, benzoyl, optionally substituted chloro- 6 alkyl monopropionyl (eg, acetyl, trifluoroacetyl, propionyl, etc.), 5- or 6-membered complex ring Karuponiru (e.g., pyridyl Ruponiru, Choi two Rukaruponiru, Furirukaruponiru etc.), C 6 - 14 Ariru Ichiriki Ruponiru (eg, Benzoiru, 1 one-naphthoyl, 2-naphthoyl, etc.), ⁇ 7 - 16 ⁇ aralkyl - Karuponiru (eg , phenylene Ruasechiru, 3-phenylpropyl propionyl, etc.), optionally halogenated C [Bok 6 alkylsulfonyl (e.g., methaneth
- Ruhoniru e.g., benzenesulfonyl, naphthylsulfonyl, etc.
- the force Rubamoiru mono- C, _ 6 alkyl Ichiriki Rubamoiru (e.g., methylcarbamoyl, Echirukaruba moil, etc.), alkyl - Power Rubamoiru (eg, dimethylcarbamoyl, Jefferies Chi carbamoyl, etc.) , aminosulfonyl, mono- alkylaminosulfonyl (eg, methylaminosulfonyl, E chill aminosulfonyl, etc.), di-C,. 6 alkylaminosulfonyl (eg, dimethylamino sulfonyl, Jechiruamino sulfonyl, etc.).
- R 7 is preferably a hydrogen atom, C, _ 6 alkyl, C alkyl -! Force Lupo two Le, force Rubamoiru, mono- C _ 6 alkyl Ichiriki Rubamoiru, di C _ 6 alkyl Ichiriki Rubamoiru, aminosulfonyl, .
- Monod C, 6 alkylaminosulfonyl, di - is C Bok 6 alkylaminosulfonyl like.
- naphthalene such as 2,3-dihydro-11-benzofuran and 1,3-dihydro-2-benzofuran Chroman; 3,4-dihydro-1H-isochromene; 2,3,4,5-tetrahydro-1-benzoxepin, 1,3,4,5-tetrahydro-2-benzoxepin, 1,2,4,5-tetrahydro-3-be Benzoxepins such as benzoxepin; benzothiophenes such as 2,3-dihydro-11-benzothiophene and 1,3-dihydro-2-benzothiophene; thiochroman; 3,4-dihydro-1H-isothiochromene; 2,3,4,5-tetrahydro 1-Venzochepine, 1,3,4,5-tetrahydr
- Benzoxazines such as 3,4-dihydro-2H-1,4 monobenzoxazine, 3,4-dihydro-12H-1,3-benzoxazine, 3,4-dihydro-2H-3,1-benzoxazine; 4-dihydro-1H-2,1,1-benzothiazine, 3,4-dihydro-1H-2,3-benzothiazine, 3,4-dihydro2H-1,2-benzothiazine, 3,4-dihydro-2H-1 Benzothiazines such as 2,4-benzothiazine, 3,4-dihydro-2H-1,3-benzothiazine, 3,4-dihydro-1H-3,1-benzothiazine; 3,4_dihydro 2H-1,2 Benzoisothiazines such as benzoisothiazine and 3,4 dihydro-1H-2,1-benzoisothiazine; 3,4 dihydro-1
- Benzodioxepins such as pin, 4,5-dihydro-1H-2,3-benzodioxepin, 1,5-dihydro-1,2,4-benzodioxepin; 4,5-dihydro-1H-2,3-benzocepin;
- Benzodicepin such as 1,5-dihydro2,4-benzodichepine, 3,4-dihydro-1H, 5-benzodichepine, 2,3-dihydro-5H_1,4benzodicepine, 3,4, Benzoxazosin such as 5,6-tetrahydro-2H-1,5-benzoxazosin, 3,4,5,6-tetrahydro-2H-1,
- Benzoxadiazepine 2,3,4,5-tetrahydro-1,3,5-benzthiadiazepines such as benzothiadiazepine; 2,3,4,5-tetrahydro-1H-1,2 Benzotriazepines such as, 5—benzotriazepine; 4,5-dihydro-1,3,2-benzoxacepine, 4,5-dihydro-1H—2,3-venzoxazepine, 3, 4-Dihydro-2H-1,5-benzoxachepin, 4,5-dihydro-3H-1,2-benzoxachepine, 4,5-dihydro-1H-3,2,1-onebenzoxache Pin, 2,3-dihydro-5H-1,4,1-benzoxachepin, 2,3-dihydro-5H-4,1,1-benz Oxachepine, especially naphthalene,
- the B 2 ′ ring may have a substituent, and may be a 5- to 9-membered nitrogen-containing heterocyclic ring, and the B 2 ′′ ring may have a substituent, a 5- to 9-membered oxygen-containing ring.
- the heterocycle and the other symbols have the same meanings as described above. And the like.
- the “5- to 9-membered nitrogen-containing heterocyclic ring” of the “optionally substituted 5- to 9-membered nitrogen-containing heterocyclic ring” in addition to a carbon atom and one nitrogen atom, for example, a nitrogen atom And a 5- to 9-membered nitrogen-containing heterocyclic ring which may contain 1 to 3 heteroatoms selected from an oxygen atom and a sulfur atom, and a 5 to 9-membered non-aromatic nitrogen-containing heterocyclic ring (for example, , Pyrrolidine, piperidine, hexamethyleneimine, heptamethyleneimine, piperazine, homopirazine, tetrahydroxazepine, morpholine, thiomorpholine, hexahydropyrimidine, imidazolysine, thiadiazolidine and the like are preferable.
- a nitrogen atom and a 5- to 9-membered nitrogen-containing heterocyclic ring which may contain 1 to 3 heteroatom
- substituents 1 to 3 substituents selected from the same as the “substituent” of the “homocyclic or heterocyclic ring optionally having substituent (s)” represented by ring B above Groups.
- substituent (s) represented by ring B above Groups.
- substituent (s) represented by ring B above Groups.
- substituent (s) represented by ring B above Groups.
- substituent (s) represented by ring B above Groups.
- substituent (s)” represented by ring B above Groups 1 to 3 substituents selected from a sulfur atom and a 5- to 9-membered non-aromatic oxygen-containing heterocyclic ring.
- substituents can be mentioned, preferably, Okiso, 6 ⁇ alkyl, C 6 alkyl one carbonyl ⁇ amino, C 6 alkylsulfonyl amino, and the like.
- the ring Ba 2 represents a homocyclic ring or a heterocyclic ring which may have a substituent
- R 7 ′ has the same meaning as R 7, and the other description has the same meaning as described above. And the like.
- location substituent of the "optionally homocyclic or heterocyclic ring may have a substituent” represented by B a 2 ring, which may have a “substituent represented by the B 2 ring Among the “substituents” of the “good homocycle or heterocycle”, one or two substituents selected from the same as those other than the oxo group can be mentioned.
- a 2 ring aminosulfonyl, mono- or di - has C 6 1 or 2 substituents selected from alkyl Ichiriki Rubamoi Le - C, _ 6 alkylamino sulfonyl, force Rubamoiru and mono - or di in benzene ring optionally, C B a 2 ring respectively, _ 6 alkyl, C, _ 6 alkyl - have force Ruponiruamino and C, a 1 or 2 substituents selected from _ 6 alkylsulphonyl ⁇ Mino And 9486
- Specific examples of the case of condensing with a ring or a heterocyclic ring, or condensing with two identical or different monocyclic homocyclic or heterocyclic rings are, for example,
- ring A 2 has the same meaning as described above, and ring C 2 and ring D 2 represent a homocyclic ring or a heterocyclic ring which may have a substituent. And the like.
- homocyclic of the "optionally substituted homocyclic” represented by ring C 2 or D 2 rings, which may have a “substituent represented by B 2 rings same And the same as the “homocycle” of the “base ring”.
- heterocycle of “optionally substituted heterocyclic ring” represented by ring C 2 or D 2 ring nitrogen atom, to 1 heteroatoms selected from oxygen atom and a sulfur atom 3 5- to 9-membered heterocyclic ring which may be contained (for example, pyridine, pyrazine, pyrimidine, imidazole, furan, thiophene, dihydropyridine, diazepine, oxazepine, pyrrolidine, piperidine, hexamethyleneimine, hepta 9486
- each symbol has the same meaning as described above.
- Specific examples of the group represented by are: anthracene, carbazolyl, 1,2,3,4,4a, 9a-hexahydrocarbazol, 9,10-dihydroacridine, 1,2 , 3,4-tetrahydroacridine, 10,11 dihydro-5H-dibenz [b, f] azepine, 5,6,7,12-tetrahydrodibenz [b, g] azosin, 6,11-dihydric mouth-5H —Dibenz [b, e] azepine, 6,7-dihydro-5H—dibenz [c, e] azepine, 5,6,11,12-tetrahydrodibenz [b, f] azosin, dibenzofuran, 9H-xanthene, 10 , 11-dihydrodibenz [b, f] oxepin, 6,11-dihydrodi
- each symbol has the same meaning as described above.
- Specific examples of the group represented by are phenalene, acenaphthylene, 1H, 3H-naphtho [1,8-cd] [1,2] oxazine, naphtho [1,8-de] -1,3-oxazine , Naphtho [1,8-de] — 1,2-oxazine, 1,2,2a, 3,4,5-hexahydrobenz [cd] indole, 2,3,3a, 4,5 , 6-Hexahydro-1H-benzo [de] quinoline, 4H-pyro [3,2,1-ij] quinoline, 1,2,5,6-tetrahydro-4H-pyro [3,2,1 — Ij] Quinoline, 5,6-dihydro-1 4H-pyro [3,2,1-ij] quinoline, 1H-pyro [3,2,1-ij] quinazoline, 4H-imidazo
- each symbol has the same meaning as described above.
- Specific examples of the group represented by are phenanthrolen, 1,2,3,6,7,8-hexahydrocyclovent [e] indole, 2,3,4,7,8,9 1-Hexahydro-1H-cyclopentene [f]
- Examples include groups formed by removing one hydrogen atom from a tricyclic fused benzene ring such as quinoline.
- the C 2 ′ ring and the D 2 ′ ring each may have a 5- to 9-membered nitrogen-containing heterocyclic ring which may have a substituent, and the other symbols have the same meanings as described above. And the like are preferred.
- C 2 'ring or D 2' "nitrogenated heterocycle of from 5 which may have a substituent 9-membered" represented by ring may have a "substituent represented by B 2 'ring And the same as the “5 to 9-membered nitrogen-containing heterocyclic ring”.
- An oxo group is preferred as the substituent.
- the C 2 '' ring and the D 2 '' ring each may have a substituent.
- a 2 ring aminosulfonyl, mono- - or di one C Bok 6 alkylamino sulfonyl, force Rubamoiru and mono- or di-C 6 alkyl - have 1 or 2 substituents selected from the force Rubamoi Le A benzene ring, wherein the C 2 '' ring and the D 2 '' ring each have one or two substituents selected from C 6 alkyl, C to 6 alkyl monoalkyl ponylamino and C!
- a phenyl group which may be condensed and the phenyl group may have a substituent”.
- Specific examples of the case of condensing with a ring or a heterocyclic ring include, for example,
- ring A 2 has the same meaning as described above, and ring E 2, ring F 2 and ring G 2 represent a homocyclic ring or a heterocyclic ring which may have a substituent. And the like.
- the ⁇ homocyclic or heterocyclic ring optionally having substituent (s) '' represented by ring E 2 , F 2 or G 2 is ⁇ having a substituent (s) represented by ring C 2 or D 2 And the like.
- the “optionally substituted 5- to 9-membered nitrogen-containing heterocycle” represented by the E 2 ′ ring, F 2 ′ ring and G 2 ′ ring is a ⁇ substituent represented by the B 2 ′ ring May have 5 Or a 9-membered nitrogen-containing heterocyclic ring ".
- an oxo group is preferable.
- [3] A group formed by removing one hydrogen atom from a tetracyclic fused benzene ring such as benzozocine.
- aromatic ring group of the “optionally condensed 5- or 6-membered aromatic ring group” represented by Ar 2 is, for example, an “aromatic heterocyclic group”, the “aromatic heterocyclic group” Examples of the condensation of
- Ar 2 is preferably, for example, of the formula
- the A 2 ring and the A 2 ′ ring include (i) halogen (fluoro, etc.), (ii) methoxy 6 alkoxy (methoxy, etc.), (iii) halogeno chloro 6 alkoxy (trifluoro methoxy, etc.), ( iv) Amino, (V) (mono or di) 6- alkylamino (methylamino, ethylamino, dimethylamino, getylamino, etc.), (vi) topirolidinyl, (vii) piperidino, (viii) topiperazinyl, (ix) N— Methyl-1-piperazinyl, (x) N-acetyl-1-piperazinyl, (xi) morpholino, (xii) hexamethyleneimino, (xiii) imidazolyl, (xiv) C, 6- alkyl (e.g. methyl) Optionally substituted C, _ 6
- the ring A 2 may have one or two substituents selected from aminosulfonyl, mono or di-C 6 alkylaminosulfonyl, dirubamoyl and mono- or di-C 6 alkyl monorubumoyl.
- a 2 'ring aminosulfonyl, mono- or di-C Bok 6 alkylaminosulfonyl, C 6 alkyl Ichiriki Ruponiruamino and C, - has one or two substituents selected from 6 alkylsulfonyl ⁇ Mino,
- it is a benzene ring which may have 1 to 4 substituents (for example, C 6 alkoxy).
- B a 2 ring, C 2 '' ring and D 2 '' ring each C DOO 6 alkyl, C -! 1 or 2 6 Ru selected from alkyl Ichiriki Ruponiruamino and C _ 6 alkylsulphonyl ⁇ Mino!
- Each of the lengths 7 and 17 ′ has (1) a hydrogen atom, and (2) each has one or two substituents selected from hydroxy and C 6 alkoxy-carbonyl.
- R 8 indicate a and R 9 'are each a hydrogen atom, halogenation which may be C 6 alkyl or C 6 _ 10 Ariru.
- the groups represented by the following formulas are preferred.
- the “main chain 1 to 10 atom spacer” in the “optionally substituted main chain 1 to 10 atom spacer” represented by L is the main chain Means an interval of 1 to 10 atoms.
- the number of atoms in the main chain is counted so that the number of atoms in the main chain is minimized.
- the number of 1,2-cyclopentylene atoms is 2, and the number of 1,3-cyclopentylene atoms is 3.
- Examples of the “substituted main chain having 1 to 10 atoms in the main chain” include, for example, —0—, —S—, CO—, —SO—, and —SO 2— , -NR 10- (R 10 is hydrogen Atom, optionally halogenated C!
- halogenated ci _ 6 alkyl one even if force Ruponiru shows halogenated may ci- 6 ⁇ alkylsulfonyl
- the bivalent which may have a substituent C - lfl acyclic hydrocarbon group
- a divalent selected from the a divalent may be C 3 9 cyclic hydrocarbon group and a divalent which may have a substituent heterocyclic group substituents Combinations of 1 to 5, preferably 1 to 3, groups are mentioned.
- substituents in the “heterocyclic group” include, for example, a halogen atom (eg, fluorine, chlorine, bromine, iodine, etc.), oxo, alkylenedioxy (eg, methylenedioxy, ethylenedioxy, etc.), nitro, cyano, halogenated _ 6 alkoxy, optionally halogenated C, _ 6 alkylthio, hydroxy, amino, mono- or di-( ⁇ _ 6 alkylamino, formyl, carboxy, carbamoyl, thiocarbam
- substituents selected from alkyl-rubumoyloxy, phenyl and the like.
- a halogen atom such as fluorine, oxo, hydroxy, phenyl and the like are preferable.
- Examples of “C i—,. Alkylene” include — CH 2 —, _ (CH 2 ) 2 —, — (CH 2 ) 31 , — (CH 2 ) 4 —, — (CH 2 ) 5 —, One (CH 2 ) 6 —, — (CH 2 ) 7 —, — (CH 2 ) 8 —, — (CH 2 ) 9 One, — (CH 2 ) 10- , — (CH 2 ) 3 CH (CH 3 ) —, One (CH 2 ) 4 CH (CH 3 ) —, One (CH 3 ) CHC —, — (CH 3 ) CH (CH 2 ) 2 —, one (CH (CH 3 )) 2 — and the like.
- C 2 —i. Alkynylene examples include 1 C 3 C 1, -CH 2 _C ⁇ C 1, -CH 2 -C ⁇ C-CH 2 -CH 2, and the like.
- C 3 - “9 cyclic hydrocarbon group which may have a substituent divalent C 3 '- 9 cycloalkylene, C 3 - 9 Shikuroa Luque two alkylene, C 6 - 14 ⁇ Li one Len (phenylene, etc.) and the like.
- the “divalent heterocyclic group” of the “optionally substituted bivalent heterocyclic group” includes, for example, 1 to 4 heteroatoms selected from a nitrogen atom, an oxygen atom and a sulfur atom 4- to 14-membered (preferably 5- to 9-membered) groups formed by removing two hydrogen atoms from an aromatic or non-aromatic complex ring.
- Examples of such an aromatic or non-aromatic heterocyclic ring include the same ones as exemplified in the above-mentioned “heterocyclic ring optionally having substituent (s)” for ring B.
- L is preferably a C i _lfl alkylene which may have a substituent, and particularly preferably has 1 or 4 substituents selected from a halogen atom, hydroxy, oxo, phenyl and the like.
- good C 2 _ 6 alkylene group e.g., one (CH 2) 2 one one (CH 2) 3 -, one (CH 2) 4 -, one (CH 2) 5 - one (CH 2) 6 -, One CHFCH 2 —, -CHF (CH 2 ) 2 One, — CHF (CH 2 ) 3 —, —CHF (CH 2 ) 4 —, One CF 2 CH 2 —, One CF 2 (CH 2 ) 2 —, One CF 2 (CH 2 ) 3 , _CF 2 (C) 4 —, — (C) 3 CH (CH 3 ) —, 1 (C) 4 CH (CH 3 ) —,-(CH 2 ) 3 CH (CF 3 ) One, —
- Examples of the ring L is formed between the A r 2, for example, Bok Okisoindan - 2-I le, 1 - Okiso -1, 2, 3, 4-tetrahydronaphthyl evening Len - 2-I le, 5- Okiso -6,7,8,9-Tetrahydro-5H-benzo [a] cyclohepten-6-yl, 2,5-dioxo-1,2,3,5,6,7-hexahydroindeno [5 , 6-d] imidazole-6-yl,, 5-dioxo-2,3,5,6,7,8-hexahydro_m-naphtho [2,3-d] imidazole-6 -Ill, 2,5-dioxo -1,2,3,5,6,7,8,9-octahydrocyclohep [f] benzimidazole-6-yl, 2,8-dioxo_2,3,4,6,7 , 8-Hexahydro-1H-
- R 11 represents a hydrogen atom or a hydrocarbon group which may have a substituent
- L 2a represents a C, _ 4 alkylene group which may have a substituent
- X represents A bond, an oxygen atom or a nitrogen atom
- Ar 3 represents an aromatic ring group which may have a substituent
- Ar 3 and R 11 , or Ar 3 and L 2a They may combine with each other to form a ring.
- R 1 1 is a "substituent" of the "optionally Good charcoal I inhibit hydrogen group which may have a substituent", "optionally substituted hydrocarbon group” represented by R 7 And the same as the “substituent” in the above, and the number of the substituents is 1 to 3.
- the “optionally substituted —4 alkylene group” for L 2a the “optionally substituted aryl group having 1 to 10 atoms for the main chain” for L
- the “C 1 () alkylene group” exemplified in “Clathe” include those having 1 to 4 carbon chains.
- L 2 which may have a substituent C, _ 4 alkylene group” represented by a “substituent” in the "number of atoms in the main may have a substituent group chain represented by L The same as the “substituent” in the “1 to 10 spacers”.
- R 1 a hydrogen atom, a substituted group optionally may be hydrocarbon groups having a Ashiru group or optionally substituted heterocyclic group are shown.
- R 1 a optionally substituted hydrocarbon group ", the" Ashiru group ",” optionally substituted heterocyclic group ", R Similar to those in 7 .
- a 3 represents an “aromatic ring group” of the “optionally substituted aromatic ring group” It is to be of same as is mentioned as “condensed may be 5 or 6-membered aromatic ring group” represented by A r 2.
- substituted of the “optionally substituted aromatic ring group” represented by A r 3 shows a “condensed may be 5 or 6-membered aromatic ring group represented by A r 2
- the aromatic ring group may have a substituent ”, and the number of the substituents is 1 to 5.
- the ring formed by combining Ar 3 and R 11 with each other is, for example, a group represented by the formula
- ⁇ and q each represent an integer of 1 to 3, and the H ring is halogen, hydride, oxy, optionally halogenated C 6 alkyl and nitrogen, optionally halogenated C 6 alkoxy. And represents a benzene ring which may have 1 to 3 substituents selected from And the like.
- the ring formed by combining Ar 3 and L 2a with each other is, for example, a compound represented by the formula
- r represents an integer of 0 to 2
- s represents an integer of 1 to 3
- r + s represents an integer of 2 to 5
- the H ring has the same meaning as described above. And the like.
- nitrogen-containing saturated heterocyclic group of the “optionally substituted nitrogen-containing saturated heterocyclic group” for Y 2 , in addition to a carbon atom and one nitrogen atom, a nitrogen atom, an oxygen
- a 5- to 9-membered (preferably 5- to 7-membered) nitrogen-containing saturated heterocyclic group which may contain 1 to 3 heteroatoms selected from atoms and sulfur atoms.
- R 1 1, (i) a hydrogen atom, (ii) a halogen atom (preferably Furuoro etc.) ⁇ 'beauty 1 substituent selected from hydroxy to 3 ⁇ also optionally may _ 4 Al kill group, or (iii) C 7 - is preferably such I6 Ararukiru (benzyl etc.), more preferably a hydrogen atom the C 1 ⁇ alkyl group.
- a halogen atom preferably Furuoro etc.
- C 7 - is preferably such I6 Ararukiru (benzyl etc.), more preferably a hydrogen atom the C 1 ⁇ alkyl group.
- L 2 a is a C 2 _ 4 alkylene group which may have 1 to 4 substituents selected from a halogen atom, hydroxy, oxo, phenyl and the like (for example, one (CH 2 ) 2 —, one (CH 2) 3 -, one (CH 2) 4 -, one CHFCH 2 -, one CHF (CH 2) 2 -, -CHF (CH 2) 3 one, - CF 2 C -, one CF 2 (CH 2 ) 2 —, one CF 2 (CH 2 ) 3 —, one (CH 3 ) CHCH 2 —, one (CH 3 ) CH (CH 2 ) 2 —, one (CH (CH 3 )) 2 —, one C3 ⁇ 4CH (0H) -, one C3 ⁇ 4C0-, - (Ph) CHCH 2 - , etc.) are preferable, hydroxy, optionally having a Okiso or phenyl C 2 - 3 alkylene group (e.g.
- X is preferably a bond, an oxygen atom or NH, and more preferably a bond.
- Ar 3 is preferably (1) a halogen (fluoro, black, etc.),
- C, _ 6 alkyl (methyl, Echiru etc.), halogeno C, _ 6 alkyl (Torifuruoro methyl, etc.), hydroxy, alkoxy (methoxy, ethoxy, etc.), halogenoalkyl alkoxy (triflate Ruo b methoxy, triflumizole Ruo b ethoxy), nits port, amino, Shiano force Rubamoiru, c, _ 6 alkyl optionally substituted with force Rubamoiru or formyl with an optionally substituted amino (NHCHO, NHC ⁇ _NH 2, NHCONHMe, etc.), C Bok 3 alkylene O carboxymethyl (Mechirenjioki sheet, etc.), C, _ 6 alkylamino which may be substituted by Cal Poni Ruo carboxymethyl group ( ⁇ iminocarbonyl O carboxymethyl, methyl ⁇ iminocarbonyl O Xy, ethylaminocarbonyl, dimethylaminoprop
- 6 alkylaminosulfonyl and di C! 6- alkylaminosulfonyl or the like may have 1 to 5 (preferably 1 to 3) substituents selected, (i) C 61 () aryl group (phenyl or the like) or ( ⁇ ) 5- or 6-membered aromatic heterocyclic group containing 1 to 4 heteroatoms selected from nitrogen atom, oxygen atom and sulfur atom (benzene ring may be condensed) (for example, phenyl, furyl, pyrrolyl) , Imidazolyl, pyrazolyl, thiazolyl, isothiazolyl, oxazolyl, isoxazolyl, pyridyl, pyrazinyl, pyrimidinyl, pyridazinyl, oxaziazolyl, thiadiazolyl, furazanil, indolyl, lysoindolyl, quinonyl, quinolyl, quinolyl
- Aryl group phenyl or the like
- Ar 2 has the formula
- a 2 ring is preferably aminosulfonyl, mono- or di-C 6 alkylaminosulfonyl, carbamo A benzene ring optionally having one or two substituents selected from aryl and mono- or di-C 6 alkyl monorubamoyl, wherein the A 2 ′ ring is preferably aminosulfonyl, monono or di-C! _.
- 6 alkylamino 'Nosuruhoniru have one or two substituents selected from C DOO 6 alkyl Lou carbonyl ⁇ amino and C 6 alkylsulfonyl ⁇ amino, further 1 to 4 substituents (e.g., 6 ⁇ alkoxy such ) in benzene ring which may have a, B a 2 ring, C 2 '' ring and D 2 "rings preferably each C Bok 6 alkyl, C WINCH 6 alkyl - carbonyl ⁇ amino and C 6 alkylsulfonyl ⁇ It may have one or two substituents selected from amino, and R 7 and R 7 ′ are preferably (1) a hydrogen atom, and (2) a hydroxy and a c 6 alkoxy monolayer, respectively. Chosen from 1 or
- a C 2 _ 6 alkylene group optionally having 1 to 4 substituents selected from a halogen atom, hydroxy, oxo, phenyl and the like (for example, 1 (CH 2 ) 2 —, 1 ( C) 3 -, one (CH 2) 4 _, one (CH 2) 5 -, one (CH 2) 6 -, one CHFCH 2 -, one CHF (C) 2 one, _CHF (CH 2) 3 - , — CHF (CH 2 ) 4 —, — CF 2 CH 2 —, — CF 2 (CH 2 ) 2 —, — CF 2 (CH 2 ) 3 —, — CF 2 (CH 2 ) 4 —, — (CH 2 ) 3 CH (CH 3 ) —, — (CH 2 ) 4 CH (CH 3 ) —,-(CH 2 ) 3 CH (CF 3 ) —, one (CH 2 ) 4 CH (CF 3 ) —, one (CH
- R 11 may have 1 to 3 substituents selected from (i) a hydrogen atom, (ii) a halogen atom (preferably fluoro and the like) and hydroxy. 4 an alkyl group, or (iii) C 7 - 16 Ararukiru (benzyl etc.) and the like;
- L 2 a is a C 2 _ 4 alkylene group which may have 1 to 4 substituents selected from a halogen atom, hydroxy, oxo, phenyl and the like (for example, — (CH 2 ) 2 —, 1 (CH 2 ) 3 —, — (CH 2 ) 4 —, —CHFC _, — CHF (CH 2 ) 2 —, — CHF (CH 2 ) 3 —, -CF 2 CH 2 , — CF 2 (CH 2 ) 2 —, One CF 2 (CH 2 ) 3 —, one (CH 3 ) CHCH 2 —, — (C) CH (CH 2 ) 2 —, one (CH (CH 3 )) 2 —, one CH 2 CH (0H ) —, C3 ⁇ 4C0—, — (Ph) CHCH 2 —, etc.);
- X is a bond, an oxygen atom or NH
- Ar 3 is (1), respectively, halogen (Furuoro, black hole like), C, _ 6 alkyl (main Chill, Echiru etc.), halogeno C WINCH 6 alkyl (triflate Ruo B methyl, etc.), hydro alkoxy, C ⁇ 6 alkoxy (methoxy, ethoxy, etc.), halogeno C ⁇ alkoxy
- aminosulfonyl, mono- C, _ 6 Arukirua Minosuruhoniru and di C! _ 6 alkylamino 1 a stone five selected from sulfonyl and the like may have a (preferably 1 to 3) substituents, (i) C 6 _ 10 Ariru group (phenyl) or (ii) a nitrogen atom, an oxygen 5- or 6-membered aromatic heterocyclic group containing 1 to 4 heteroatoms selected from an atom and a sulfur atom (a benzene ring may be condensed) (for example, chenyl, furyl, pyrrolyl, imidazolyl, pyrazolyl, Thiazolyl, isothiazolyl, oxazolyl, isoxazolyl, pyridyl, pyrazinyl, pyrimigel, pyridazinyl, oxadiazolyl, thiadiazolyl, furazanil, indo
- Ar 4 represents a bicyclic may have a substituent or tetracyclic condensed benzene ring group, L, represents the optionally having C 4. 6 alkylene group substituents, The other symbols of 'are as defined above. (Hereinafter, it may be abbreviated as compound (Ila)) or a salt thereof is a novel compound.
- bicyclic or tetracyclic condensed benzene ring group of the "two may have a substituent ring or tetracyclic fused base Nze down ring group” represented by Ar 4, Ru indicated by Ar 2
- the “5- or 6-membered aromatic ring group” of the “optionally condensed 5- or 6-membered aromatic ring group” is a “phenyl group”
- the A 2 ring (i) halogen (Furuoro etc.), (11) Bok 6 an alkoxy (methoxy, etc.), (iii) a halogeno C Bok 6 alkoxy (triflate Ruo b methoxy, etc.), (iv) Amino (V) (mono or di) 6- alkylamino (methylamino, ethylamino, dimethylamino, acetylamino, etc.), (vi) 1-pyrrolidinyl, (vii) piperidino, (viii) 1-piperazinyl, (ix) N - methyl - 1 - piperazinyl, (x) N-Asechiru - Bok piperazinyl, esterified with (xi) morpholino, (xii) hexamethylene I Mino, (xiii) imidazolyl, (xiv) C Bok 6 alkyl (methyl, etc.) is a
- the ring A has one or two substituents selected from aminosulfonyl, mono- or di-C 6 -alkylaminosulfonyl, dirubamoyl and mono- or di-C 6 alkyl mono-rubbamoyl.
- aminosulfonyl mono- or di-C 6 -alkylaminosulfonyl
- dirubamoyl mono- or di-C 6 alkyl mono-rubbamoyl.
- a good Benzen's ring A good Benzen's ring.
- B a 2 ring, C 2 '' ring and D 2 '' ring each C 6 alkyl, C ⁇ - 6 Ru is selected from alkyl Ichiriki Ruponiruamino and C 6 alkylsulfonyl ⁇ amino 1 or 2 substituents
- each of 17 and 7 ′ is (1) a hydrogen atom, and (2) each optionally having one or two substituents selected from hydroxy and C 6 alkoxy-carbonyl.
- L, in the "optionally substituted C 4. 6 alkylene group” represented as the to “C 1 atom may also be the main chain have a substituent group represented by L 10 of the scan page Examples of the “C 1.
- Alkylene group” exemplified in “Sir” include those having 4 to 6 carbon chains.
- a "location substituent" of the "substituent optionally C 4 _ 6 alkylene group which may have a” represented "atoms in the main may have a substituent group chain represented by L
- substituent group chain represented by L Examples are the same as the “substituent” in 1 to 10 spacers.
- a halogen atom eg, fluorine, chlorine, bromine, iodine, etc.
- nitro, cyano optionally halogenated alkoxy, hydroxy, etc.
- substituents include 1 to 4 substituents.
- L is preferably, for example, — (CH 2 ) 4 —, one (CH 2 ) 5 —, _ (CH 2 ) 6 —, one CHF (C) 3 _, — CHF (C) 4 —, one CF 2 (CH 2 ) 3 —, —CF 2 (CH 2 ) 4 —,-(CH 2 ) 3 CH (CH 3 ) one, — (CH 2 ) 4 CH (CH 3 ) _, one (CH 2 ) 3 CH (CF 3 ) _, one (CH 2 ) 4 CH (CF 3 ) — and the like.
- Ar 4 has the formula
- R 11 may have 1 to 3 substituents selected from (i) a hydrogen atom, (ii) a halogen atom (preferably fluoro and the like) and hydroxy. 4 alkyl group, 'or (iii) C 7 _ 16 Ararukiru (benzyl etc.) and the like (more preferably a hydrogen atom or C: _ 4 alkyl group);
- L 2 is a halogen atom, hydroxy, Okiso, 1 to may have four substituents C 2 are selected from phenyl, etc. - 4 alkylene group (e.g., one (CH 2) 2 -, - (C3 ⁇ 4) 3 —, one (CH 2 ) 4 —, — CHFC —, one CHF (CH 2 ) 2 —, _CHF (CH 2 ) 3 —, -CF 2 CH 2 —, — CF 2 (CH 2 ) 2 —, — CF 2 (CH 2 ) 3 —, — (CH 3 ) CHCH 2 —, one (CH 3 ) CH (CH 2 ) 2 —, one (CH (CH 3 )) 2 —, — CH 2 CH (0H) — , —CH 2 C0—, — (Ph) CHCH 2 — or the like (more preferably a C 2 _ 3 alkylene group optionally having hydroxy, oxo or pheny
- X is a bond, an oxygen atom or NH (more preferably a bond);
- a r 3 is (1), respectively, halogen (Furuoro, black hole, etc.), C, _ 6 alkyl (methylation, Echiru etc.), halogeno C,. 6 alkyl (triflate Ruo B methyl, etc.), hydro alkoxy, C ⁇ e alkoxy (methoxy, ethoxy, etc.), halogeno C Doo 6 alkoxy (triflate Ruo b methoxy, triflumizole Ruo b ethoxy), nitro, Amino, Xia Roh, force Rubamoiru, C, may be substituted by _ 6 alkyl force Rubamoiru or e mill amino optionally substituted with (NHCH_ ⁇ , NHC_ ⁇ _NH 2, NHCO NHMe, etc.), C, .3 alkylene O carboxymethyl (Mechirenjiokishi etc.), C, substituted with _ 6 Al kill Good aminocarponyloxy groups (aminoaminopropyl, methyla
- a substituent may have a (preferably 1 to 3) substituents, (i) C 6 _ 1 0 Ariru group (phenyl Or (ii) a 5- or 6-membered aromatic heterocyclic group containing 1 to 4 heteroatoms selected from a nitrogen atom, an oxygen atom and a sulfur atom (a benzene ring may be condensed) (for example, chenyl , Frill, pyrrolyl, imidazolyl, pyrazolyl, thiazolyl, isothiazolyl, oxazolyl, isooxazolyl, pyridyl, pyra Dinyl, pyrimidinyl, pyridazinyl, oxa'diazolyl, thiadiazolyl, flazanil, indolyl, isoindolyl, benzofuranyl, quinolyl, isoquinolyl, naphthyridinyl, quinazolinyl,
- a r 3 is more preferably halogen, nitro, hydroxy, optionally halogenated C 6 alkyl, optionally halogenated C 6 alkoxy and aminosulfonyl, respectively) 1 selected from but it may also have three substituents, selected from (i) C 6 _ 1 0 ⁇ Li Ichiru group (phenyl) or (ii) a nitrogen atom, an oxygen atom and a sulfur atom Or a 5- or 6-membered aromatic heterocyclic group containing 1 to 4 hetero atoms (which may have a benzene ring condensed) (Chenyl, indolyl, etc.).) And the like. 'In addition, among the compounds ( ⁇ ), the formula
- Ar 5 represents a benzimidazole ring group, a quinazoline ring group, a 1,4-benzoxazine ring group or a tricyclic or tetracyclic fused benzene ring group which may have a substituent.
- L 3 represent a C 2 _ 4 alkylene group which may have a substituent, and other items have the same meanings as described above. (Hereinafter sometimes abbreviated as compound (lib) ′) or a salt thereof is a novel compound.
- the ⁇ tricyclic or tetracyclic fused benzene ring group '' of the ⁇ tricyclic or tetracyclic fused benzene ring group which may have a substituent '' represented by A r 5 is represented by Ar
- a r 5 represents a “benzimidazole ring group, a quinazoline ring group, a 1,4-benzoxazine ring group or a tricyclic or tetracyclic condensed benzene ring group, each of which may have a substituent”.
- substituent group "represents a" condensed may be 5 or 6-membered aromatic ring group represented by a r 2, as the "substituent" of the aromatic Kowamoto may have a substituent " The same substituents as mentioned above can be mentioned.
- the “substituent” in the “optionally substituted C 2 _ 4 alkylene group” represented by L 3 includes the “number of atoms of the main chain optionally substituted” represented by L Examples are the same as the “substituent” in “1 to 10”.
- a halogen atom eg, fluorine, chlorine, bromine, iodine, etc.
- nitro e.g., cyano, optionally halogenated- 6 alkoxy, hydroxy and the like.
- L 3 is, for example, — (CH 2 ) 2 —, — (CH 2 ) 3 —, — (GH 2 ) 4 —, _ CHFCH 2 —, — CHF (CH 2 ) 2 —, — CF 2 CH And C 2-4 alkylene groups which may have one or two halogen atoms, such as 2 — and one CF 2 (CH 2 ) 2 —.
- Ar 5 has the formula
- L is one (C 2) '2 (CH, 2)' 3 CHFCH, — CHF (CH 2 ) 2 —, -CF 3 ⁇ 4 2C3 ⁇ 4 ”2-,-
- a C 2 _ 3 alkylene group (more preferably an ethylene group) which may have one or two halogen atoms such as CF 2 (C) 2 —;
- L 2 is-(C) 2 —, one (CH 2 ) 3 —, — CF 2 C —, one CF 2 (C) 2 —, one (C) CHCH 2 —, or — (CH 3 ) CH (CH 2 ) 2 —, — CH 2 CH (0H) —, — CH 2 C0—, 1 (Ph) CHCH 2 —, etc., and 1 to 4 substituents selected from hydroxy, oxo, phenyl, etc.
- a C 2 _ 4 alkylene group which may have (more preferably a C 2 -3 alkylene group which may have a hydroxy, oxo or phenyl);
- X is a bond, an oxygen atom or NH (more preferably bond or an oxygen atom);
- a r 3 is (1), respectively, halogen (Furuoro, black hole, etc.), C, _ 6 alkyl (methylation, Echiru etc.) , halogeno C, _ 6 alkyl (triflate Ruo b methyl, etc.), hydro alkoxy, C, _ 6 alkoxy (methoxy, ethoxy, etc.), halogeno C WINCH 6 alkoxy (triflate Ruo b methoxy, triflumizole Ruo b ethoxy), nitro, amino, Xia Roh, Karupamoiru, C, _ 6 alkyl substituted by optionally substituted by also good force Rubamoiru or e mill have amino (NHCHO, NHC_ ⁇ _NH 2, NHCO NHMe, etc.), C, _ 3 alkyl Rangeoxy (methylenedioxy etc.), C ⁇ Al Amino
- C, 1 a stone five selected from _ 6 alkyl aminosulfonyl like (preferably 1 may have a substituent three), four to (i) C 6_ 1 0 Ariru group (phenyl) or (ii) a nitrogen atom, no heteroatom 1 selected from oxygen atom and a sulfur atom 5- or 6-membered aromatic heterocyclic group containing (a benzene ring may be condensed) (For example, chenyl, frill, pyrrolyl,
- Ar 6 has one or two substituents selected from aminosulfonyl, mono or di-C 6 alkylaminosulfonyl, C 6 alkyl-carbonylamino and C! _ 6 alkylsulfonylamino, Further, it represents a benzene ring group which may have 1 to 4 substituents, and the other description is as defined above. (Hereinafter sometimes abbreviated as compound (lie)) or a salt thereof is a novel compound.
- substituted base groups may have a Nze down ring group” represented by Ar 6, was also be 5 or optionally combined "condensed represented by Ar 2 Represents a 6-membered aromatic ring group, and the aromatic ring group may have a substituent ”and is the same as the substituent described as the“ substituent ”(provided that aminosulfonyl, monono or di-C! _ 6 alkylaminosulfonyl, C, - 6 alkyl - excluding force Ruponiruamino Contact and C 6 alkylsulfonyl ⁇ Mino) and the like.
- Ar 6 is one or two selected from aminosulfonyl, mono or di-C 6 alkylaminosulfonyl, C 6 -alkyl alkyl monosulfonylamino and C! _ 6 alkylsulfonylamino (Preferably 1) substituents, and 1 or 2 (more preferably 1) additional! A benzene ring group optionally having 4 alkoxy;
- R 1 1 is (i) a hydrogen atom, (ii) a halogen atom (preferably Furuoro etc.) 1 substituent to 3 have _ 4 may be alkyl group selected from and hydro alkoxy, or (iii) C 7 _ 16 aralkyl (such as benzyl) (more preferably a hydrogen atom or c, _ 4 alkyl group);
- L 2 is a halogen atom, hydroxy, Okiso, to 1 selected from phenyl or the like which may have a four substituents C 2 - 4 alkylene group (e.g., - (CH 2) 2 - , - (C) 3 —, — (CH 2 ) 4 —, — CHFCH 2 —, —CHF (CH 2 ) 2 —, one CHF (CH 2 ) 3 —, one CF 2 CH 2 1, _CF 2 (CH 2 ) 2 —, One CF 2 (CH 2 ) 3 —, — (CH 3 ) CHCH 2 —, — (C) C cold 2 ) 2 —, One (CH (C3 ⁇ 4)) 2 —, — CH 2 CH (0H) —, — CH 2 C0-, one (Ph) CHCH 2 -, etc.) (more preferably hydroxy or may have Okiso C 2 - 3 alkylene group);
- X is a bond, an
- a r 3 is (1), respectively, halogen (Furuoro, black hole like), CH alkyl (methylation, Echiru etc.), halogeno C,. 6 alkyl (triflate Ruo B methyl, etc.), hydro alkoxy, C,. 6 alkoxy (Methoxy, ethoxy, etc.), halogeno C ⁇ 6 alkoxy
- Ar 2 is more preferably halogen, nitro, hydroxy, optionally halogenated C 6 alkyl, optionally halogenated C 6 alkoxy and aminosulfoel, respectively) it 1 selected from but it may also have three substituents, (i) C 6 - 1Q Ariru group (phenyl) or (ii) a nitrogen atom, Ji port to be selected from an oxygen atom and a sulfur atom 5- or 6-membered aromatic heterocyclic group containing 1 to 4 atoms (benzene ring may be condensed) (Chenyl, indolyl, etc.).
- n 2 represents an integer of 1 or 2
- L 4 good C 3 may have a substituent - indicates 5 alkylene group, other serial are as defined above. (Hereinafter sometimes abbreviated as compound (lid)) or a salt thereof is a novel compound.
- L as "substituent” in the "optionally substituted C 3 _ 5 alkylene group” represented by 4, the number atoms "in the main may be substituted chains represented by L 1 And the same as the “substituent” in “10 to 10”.
- substituent for example, eight androgenic atom (e.g., fluorine, chlorine, bromine, iodine), Two Toro, Shiano, optionally halogenated ( ⁇ - 6 alkoxy, 1 to 4 substituents selected from such hydroxy Is mentioned.
- R 7 and R 7 ' is an optionally hydrogen atom or a halogenated C Bok 6 alkyl group (methyl, Echiru, triflumizole Ruo b methyl, etc.); L 4 gar (CH 2 ) 3 —, — (CH 2 ) 4 —, — (CH 2 ) 5 —, —CHF (CH 2 ) 2 —, — CHF (CH 2 ) 3 —, one CF 2 (CH 2 ) 2 —, — CF 2 (CH 2) 3 -, - (CH 2) 2 CH (C) -, one (CH 2) 3 CH (C3 ⁇ 4 ) - such as one or two good C 3 one may have a halogen atom 5 alkylene groups (more preferably C 3 _ 4 alkylene groups);
- R 11 may have 1 to 3 substituents selected from (i) a hydrogen atom, (ii) a halogen atom (preferably fluoro and the like) and hydroxy. 4 an alkyl group, or (iii) C 7 _ 16 Ararukiru (benzyl etc.) and the like (more preferably a hydrogen atom or a C 1 _ 4 alkyl group);
- L 2 is a C 2 _ 4 alkylene group which may have 1 to 4 substituents selected from a halogen atom, hydroxy, oxo, phenyl and the like (for example, — (CH 2 ) 2 —, — (CH 2 ) 3 —, — (CH 2 ) 4 _, — CHFCH 2 —, — CHF (CH 2 ) ”, one CHF (CH 2 ) 3 —, — CF 2 CH 2 —, — CF 2 (CH 2 ) 2 — — — CF 2 (CH 2 ) 3 —, — (CH 3 ) CHCH 2 —, one (CH 3 ) CH (CH 2 ) 2 —,-(CH (C)) 2 _, —CH 2 CH (0H) —, — CH 2 C0—, — (Ph) CHCH 2 — or the like (more preferably a C 2 _ 3 alkylene group optionally having hydroxy or oxo
- a r 3 is (1), respectively, halogen (Furuoro, black hole, etc.), C, _ 6 alkyl (methylation, Echiru etc.), halogeno C, _ 6 alkyl (triflate Ruo B methyl, etc.), hydro alkoxy, C, _ 6 alkoxy (methoxy, ethoxy, etc.), halogeno C 6 alkoxy (trifluoromethyl, trifluoroethoxy, etc.), nitro, amino, shear Bruno, force Rubamoiru, C, _ 6 alkyl amino which may be substituted by which may be force Rubamoiru or e mill substituted (NHCHO NHCONH 2 NHCO NHMe, etc.), C!.
- C, _ 6 may aminocarbonyl optionally substituted by Al kill O alkoxy group (amino force Ruponiruo carboxymethyl, methyl ⁇ iminocarbonyl O carboxymethyl, Echiruamino force Ruponiruokishi, dimethyl Chiruamino force Ruponiruokishi, Jefferies chill ⁇ amino Cal Poni Ruo carboxymethyl etc.
- Ar 3 is more preferably halogen, nitro, hydroxy, optionally halogenated C 6 alkyl, optionally halogenated C 6 alkoxy And to 1 selected from aminosulfonyl but it may also have three substituents, selected from (i) C 6 _ 1 0 Ariru group (phenyl) or (ii) a nitrogen atom, an oxygen atom and a sulfur atom Or a 5- or 6-membered aromatic heterocyclic group containing 1 to 4 hetero atoms (which may be condensed with a benzene ring) (such as phenyl or indolyl). )
- compound B When the compound (II), (I la), (lib), (lie) or (lid) (hereinafter, referred to as “compound B”) is a salt, examples of such a salt include inorganic Examples thereof include salts with bases, ammonium salts, salts with organic bases, salts with inorganic acids, salts with organic acids, and salts with basic or acidic amino acids.
- the salt with an inorganic base include alkali metal salts such as sodium salt and potassium salt; alkaline earth metal salts such as calcium salt, magnesium salt and barium salt; and aluminum salt.
- salt with an organic base examples include salts with trimethylamine, triethylamine, pyridine, picoline, ethanolamine, diethanolamine, tomin and the like.
- salts with inorganic acids include salts with hydrochloric acid, hydrobromic acid, nitric acid, sulfuric acid, phosphoric acid, and the like.
- salts with organic acids include, for example, formic acid, acetic acid, trifluoroacetic acid, fumaric acid, oxalic acid, tartaric acid, maleic acid, citric acid, succinic acid, malic acid, methanesulfonic acid, benzenesulfonic acid, p — Salts with toluenesulfonic acid and the like.
- salts with a basic amino acid include, for example, salts with arginine, lysine, orditin
- salts with an acidic amino acid include, for example, aspartic acid, glutamic acid, and the like.
- pharmaceutically acceptable salts are preferred.
- Compound B when Compound B has an acidic functional group, it may be an inorganic metal such as an alkali metal salt (eg, sodium salt, potassium salt, etc.) or an alkaline earth metal salt (eg, calcium salt, magnesium salt, barium salt, etc.). Salts and ammonium salts may be used.
- an alkali metal salt eg, sodium salt, potassium salt, etc.
- alkaline earth metal salt eg, calcium salt, magnesium salt, barium salt, etc.
- compound B When compound B has a basic functional group, it may be an inorganic salt such as hydrochloride, sulfate, phosphate, or hydrobromide; or acetate, maleate, fumarate, or succinic acid.
- Organic salts such as salts, methanesulfonate, P-toluenesulfonate, citrate and tartrate may be used.
- Compound B may be either an anhydride or a hydrate. In the case of a hydrate, it may have 0.1 or 5 water molecules.
- compound B may be labeled with an isotope (eg, 3 H, 14 C, 35 S, etc.).
- an isotope eg, 3 H, 14 C, 35 S, etc.
- compound B contains an optical isomer, a stereoisomer, a positional isomer, and a rotamer, these are also included as the compounds of the present invention, and each of them is formed as a single product by a synthesis method and a separation method known per se. Obtainable.
- the compound B when the compound B has an optical isomer, the compound B includes the optical isomer resolved from the compound.
- the optical isomer can be produced by a method known per se. Specifically, an optical isomer is obtained by using an optically active synthetic compound or by optically resolving the final racemic mixture according to a conventional method.
- optical resolution method a method known per se, for example, a fractional recrystallization method, a chiral column method, a diastereomer method and the like described in detail below are used.
- Racemic and optically active compounds eg, (+)-mandelic acid, (-)-mandelic acid, (+)-tartaric acid, (-)-tartaric acid, (+)-1-phenethylamine, (-)-1-phenene
- Chiral column method A method in which a racemate or a salt thereof is applied to an optical isomer separation column (chiral column) for separation.
- a chiral column such as ENANTIO-0VM (manufactured by Toso I) or CHIRAL series manufactured by Daicel, and water, various buffers (for example, phosphate buffer)
- the optical isomers are separated by developing an organic solvent (eg, ethanol, methanol, isopropanol, acetonitrile, trifluoroacetic acid, getylamine, etc.) alone or as a mixed solution.
- an organic solvent eg, ethanol, methanol, isopropanol, acetonitrile, trifluoroacetic acid, getylamine, etc.
- separation is carried out using a chiral column such as CP—Chirassi 1—DeXCB (manufactured by Diesel Sciences).
- a racemic mixture is formed into a mixture of diastereomers by a chemical reaction with an optically active reagent, which is converted into a single substance through ordinary separation means (for example, fractional recrystallization, chromatography, etc.), and then subjected to a hydrolysis reaction.
- a method for obtaining optical isomers by separating optically active reagent sites by chemical treatment such as For example, when compound B has hydroxy or primary or secondary amino in the molecule, the compound and an optically active organic acid (for example, MTPA [hydroxy-methoxy- (trifluoromethyl) phenylacetic acid]), (1) -menthoxyacetic acid, etc.) to give a diastereomer of an ester form or an amide form, respectively.
- an optically active organic acid for example, MTPA [hydroxy-methoxy- (trifluoromethyl) phenylacetic acid]
- an amide or ester diastereomer can be obtained by subjecting the compound to an optically active amine or an alcohol reagent for a condensation reaction.
- the separated diastereomer is converted into an optical isomer of the original compound by subjecting it to an acid hydrolysis or a basic hydrolysis reaction.
- a prodrug of compound B is a compound that is converted to compound B by a reaction with an enzyme or stomach acid under physiological conditions in a living body, that is, a compound that is enzymatically oxidized, reduced, hydrolyzed, etc. to change to compound B.
- prodrugs of compound B include compounds in which the amino group of compound B is acylated, alkylated, and phosphorylated [e.g., the amino group of compound B is eicosanoylated, alanylated, pentylaminocarbonyl Methylated, (5-methyl-2-oxo_1,3-dioxolen-141-yl) methoxycarbonylation, tetrahydrofuranylation, pyrrolidylmethylation, bivaloyloxymethylation, tert-butylated compounds, etc.]
- a compound in which the hydroxyl group of compound B has been acylated, alkylated, phosphorylated, or borated (eg, the hydroxyl group of compound B has been acetylated, palmitoylated, propanoylated, bivaloylated, succinylated, fmalylated, aranylated, Compounds in which the carboxyl group of
- the prodrug of compound B may be a compound that changes to compound B under physiological conditions, as described in Hirokawa Shoten, 1990, “Development of Drugs,” Vol. 7, Molecular Design, pp. 163 to 198. Good.
- the compound of the formula (I) or a salt thereof can be produced by a method known per se or a method analogous thereto. Specifically, in the above formula,
- a monocyclic heterocyclic ring optionally represented by Ar wherein “a phenyl group which may be condensed, and the phenyl group may have a substituent”
- JP-A-5140149 EP-A-0487071
- JP-A-6-1666763 ⁇ 4 EP-A-05602353 ⁇ 4
- JP-A-6-206875 EP-A-05670903 ⁇ 4
- 169569 USP 4,895,841 3 ⁇ 4
- a bicyclic heterocyclic ring represented by Ar which may be a phenyl group which may be condensed, and the phenyl group may have a substituent.
- Ar is a phenyl group which may be condensed, and the phenyl group may have a substituent.
- the target product may be produced according to the method described in JP-A-7-309835 (EP-A-0655451).
- R laa is phenyl, phenyl _C 6 alkyl, cinnamyl or heteroarylmethyl (where the heteroaryl group is imidazo-mouth, thiazolo, thieno, piano Phenyl and heteroaryl groups may have one or two substituents selected from C, 6 alkyl, C, 6 alkoxy and halogen.
- R 2aa and R 3aa each independently represent a hydrogen atom, C 6 alkoxy, a C 6 alkyl group which may be substituted by 1 to 3 fluorines, benzyloxy, hydroxy, phenyl, benzyl, halogen, nitro, Cano, CO0R 4aa , C ⁇ NHR 4aa , NR 4aa R 5aa , NR 4aa C ⁇ R 5aa or SOp aa CH 2 Ph (where p aa represents 0, 1 or 2) or R 2aa R 3aa may form a 5- or 6-membered ring together with adjacent carbon atoms (the constituent atoms of the ring are carbon, nitrogen and oxygen), for example, a methylenedioxy, ethylenedioxy or lactam ring.
- R 4aa and R 5aa are each independently hydrogen Or indicating the atom or C! _ 6 alkyl group, NR aa R 5aa of R 4aa and R 5aa other constituent atoms of 4 to 8 membered ring containing at least one nitrogen atom together with the adjacent nitrogen atom (ring carbon, Oxygen or nitrogen.) May be formed.
- the NR 4aa C_ ⁇ _R R 4aa and R 5aa in 5aa may form a 4 to co and the adjacent nitrogen and carbon atoms to 8-membered lactam ring.
- X aa represents nitrogen or CH
- Y aa represents oxygen, zeo or NR 6aa .
- R 6aa is a hydrogen atom, C, _ 6 alkyl, CO-C! _ 6 alkyl or SO 2 -phenyl (where the phenyl group is 1 to 5 substituents independently selected from C 4 alkyl May be included).
- n aa represents an integer of 1 to 4, each aa independently represents 1 or 2, and Z aa represents oxygen or zeo. Or a salt thereof.
- Specific examples include 1- (2-methyl-1H-benzimidazole-5-yl) — 3 -— [1- (phenylmethyl) _4-piperidinyl] — 1-propanone, 1- (6-methylbenzo [b] — 2—yl) — 3— [1— (phenylmethyl) —4—piberidinyl] —1-propanone, 1— (6-methylindole-2-yl) — 3— [1— (phenylmethyl) — 4-piberidinyl] -11-propanone and the like.
- the above compound or a salt thereof is produced by the method described in WO93Z07140 or a method analogous thereto.
- R 1 bb and R 2 bb are each a hydrogen atom, _ 6 alkoxy, benzyloxy, phenoxy, hydroxy, phenyl, benzyl, halogen, nitro, cyano, formula: COR 5 bb , -COO 5 bb , -CONH 5 bb , -NR 5 b R 6 bb or NR 5 bb COR 6 bb (where
- R 5 bb and R 6 bb are each i) a hydrogen atom, ii) C, _ 6 alkyl, iii) Halogen, Ci _ 4 alkyl, triflumizole Ruo Russia methyl, C x _ 4 alkoxy, Xia Roh, a substituent selected from nitro and hydroxy optionally having 1 or 2 respectively phenyl or benzyl; or
- R 5 bb and R 6 bb of NR 5 bb R 6 b together form a 4- to 8-membered nitrogen-containing ring
- R 5 bb and R 6 bb of NR 5 bb COR 6 bb together form a 4- to 8-membered lactam ring), which is substituted with 1 to 3 fluorine atoms.
- R 1 bb and R 2 bb are bonded to the adjacent carbon atom and X bb is oxygen, sulfur or NR 4 bb - If (R 4 bb is hydrogen or 4 alkyl) Ru der, they bind Formula with carbon atoms
- J bb is oxygen, sulfur or NR 4 bb ,
- a bb is 1 or 2
- R 3 bb is hydrogen or 1-6 alkyl
- 1 bb represents an integer of 1 to 3.
- L bb is i) halogen, - 6 alkyl, _ 6 alkoxy, Ci - 6 alkoxy - Karuponiru or _ 6 alkyl - phenyl which may have three, respectively, 1 to substituents selected from carbonyl or phenylene Lou _ 6 ⁇ alkyl, ii) cinnamyl, iii) pyridylmethyl, or iv) wherein:
- b bb is an integer of 1 to 4,
- R 13 bb and R 14 bb are each hydrogen, — 4 alkyl, halogen or phenyl,
- E bb and F bb are each — CH— or nitrogen
- Gbb represents oxygen, sulfur or NR 4 bb (R 4 bb is as defined above). However, when E bb and F bb are both nitrogen, one of Ri s bb and R 14 bb does not exist.
- R 7 bb and R 8 bb are each hydrogen, — 6 alkyl, — 6 alkoxy-carbonyl, C, 6- alkyl-carbonyl or C! ⁇ 6 Indicates alkoxy. Provided that the - 6 alkoxy not bonded to the carbon atom adjacent to the nitrogen. ] The compound represented by these, or its salt.
- ring Acc is benzo, thieno, pyrido, virazino, pyrimido, furano, serenolo or pyrrole;
- R 2 cc is hydrogen, Ci _ 4 alkyl, benzyl, Furuoro or Shiano;
- R 3 c c, R 4 cc, R 5 cc and R 6 cc is - 6 alkoxy, Benjiruokishi, phenoxy, hydroxy, phenyl, benzyl, C androgenic, nitro, Shiano, One COOR 9 cc One CONHR 9 cc, one NR 9 c c R 1 ° cc , -NR 9 c c COR 1.
- cc, or _ 6 alkyl optionally substituted with 1 to 3 fluorine atoms;
- R 3 cc, R 4 cc , R 5 cc and R 6 cc are taken together with an adjacent carbon atom so that each atom of the ring together with the adjacent carbon atom is carbon, nitrogen or oxygen. Or forms a 6-membered ring (eg, a methylenedioxy, ethylenedioxy or lactam ring);
- R 9 cc and R 1 ° cc are each hydrogen or monofialkyl , or N R 9 .
- R 9 and Rl 0 are nitrogen 1 TsunoHara terminal of connexion ring such together, others form a 4 to 8-membered cyclic amino group is a carbon, or NR 9 c c COR 1 Q c c of R 9 c c and R 1 .
- cc together form a 4- to 8-membered cyclic lactam ring;
- G cc is carbon or nitrogen
- E cc is carbon, nitrogen, oxygen, sulfur, sulfoxide or sulfone
- the carbon at any one of the 1, 2-, or 3_ positions of the ring D cc is adjacent to the carbonyl group, it may be optionally substituted with nitrogen (the carbon may be 1-, 2
- the ring is a lactam ring because it is in the 1- or 3-position);
- X cc is ⁇ , S, NOR 1 cc , hydrogen or _6 alkyl (provided that the ring D cc atom to which X cc is bonded is carbon and X cc is ⁇ , S, NOR 1 cc Only, X cc is double-bonded to ring D cc);
- R 1 cc is hydrogen or _ 6 alkyl
- q cc is 1 or 2;
- n cc is an integer of 1 to 3
- n cc is 0 or an integer of 1 to 3
- M cc is carbon or nitrogen
- L CC is phenyl, phenyl - Ci one 6 alkyl, cinnamyl or Pirijirume chill (said phenyl and phenyl - - 6 alkyl, - 6 alkyl, C
- R 1 1 cc is hydrogen, halogen, hydroxy, C x _ 4 alkyl, C x _ 4 alkoxy or oxygen;
- R 1 2 cc and R 1 3 cc each, hydrogen, Furuoro, hydroxy, Aseto carboxymethyl, o- mesylate, o_ tosylate, C, _ 4 alkyl or _ 4 alkoxy; or
- R 12 cc and R 13 cc are attached to a carbon atom, they together with the atom to which they are attached form a 3- to 5-membered ring in which each atom of the ring is carbon or oxygen. Formation;
- R 7 cc and R 8 cc each, hydrogen, _ 6 alkyl or _ 6 ⁇ alkoxy (the one 6 alkoxy, nitrogen, (E - adjacent to 6 alkoxy Ichiriki Ruponiru per cent and E _ 6 alkyl Ichiriki Ruponiru Does not bind to carbon); or
- R 8 cc and R 12 cc together with the atom to which they are attached form a 4- to 7-membered saturated carbocyclic ring (one of the above carbon atoms is replaced by oxygen, nitrogen or sulfur) May be).
- E cc is carbon, nitrogen, oxygen, sulfur, sulfoxide or sulfone, G cc is carbon;
- G cc is nitrogen, E cc is carbon or nitrogen;
- R 2 e when G cc is carbon when both E cc and G cc are nitrogen, and when E cc is oxygen, sulfur, sulfoxide or sulfone.
- each of the atoms at the 1-, 2- and 3-positions of ring 0 is not bonded by more than one double bond;
- R 11 cc is oxygen A double bond to the ring D cc and a single bond to the ring D cc when R 11 cc is other than oxygen;
- both X cc and R 11 cc are oxygen and each of the ring D ec When attached to the 1- and 3-position carbons, or respectively attached to the 3- and 1-position carbons of ring D cc, the 2-position carbon of ring D cc is replaced by nitrogen.
- X dd is hydrogen, lower alkyl, lower alkoxy, hydroxy or nitrate; Y dd is hydrogen or lower alkoxy; or X dd and Y dd are bonded together to form a group OCH 2 O— In this case, the Xdd and Ydd positions of the benzene ring must be adjacent to each other); Z dd is hydrogen, lower alkyl, lower alkoxy, hydroxy, halogen or nitro; n dd is 0 or 1 .
- the above compound or a salt thereof can be prepared by the method described in Japanese Patent Application Laid-Open No. 6-116237 / EP-A-5 172 21 USP 5, 106, 856 or a method similar thereto. It is manufactured by the following method.
- R 2 ee is hydrogen, cyano, CH 2 NR 8 ee R 9 ee , CONHR 5 ee or C ⁇ NR 6 ee R 7 ee ;
- R 3 ee is
- R 4 ee is hydrogen, halogen, lower alkyl or lower alkoxy;
- R 5 e is hydrogen, lower alkyl or aryl lower alkyl;
- R 6 ee is lower alkyl or aryl lower alkyl;
- R 7 e e is lower alkyl or aryl lower alkyl;
- R 8 ee is hydrogen, lower alkyl, aryl lower alkyl or acyl;
- R 9 ee is hydrogen, lower alkyl or aryl lower alkyl; ee is lower alkyl, aryl or aryl lower alkyl.
- R 2 ee is not hydrogen.
- the compound represented by these, or its salt include 1-methyl-41- (4-cyano-7-methoxy-2-benzofuranyl) piperidine, 1-methyl-4_ (4-N, N-getylamide-7-methoxy-2-benzene) Zofuranyl) piperidine, 1-methyl-4- (4_N, N-getylaminomethyl-7-methoxy-21-benzofuranyl) piperidine and the like.
- the above compound or a salt thereof is produced by the method described in JP-A-7-109275 or a method analogous thereto.
- X ff is hydrogen, halogen, lower alkoxy, lower alkyl, hydroxy or trifluoromethyl;
- m ff is 1 or 2;
- R xff is hydrogen or lower alkyl;
- R 2 ff is hydrogen;
- the above compound or a salt thereof is prepared according to the method described in WO 97/37992 or Manufactured by a similar method.
- gg is C 5 _ 7 cycloalkyl group, phenyl group or a 4 ⁇ alkyl group, - 4 alkoxy group, phenyl group substituted with a nitro group or a halogen atom
- R 2 gg and R 3 gg is , hydrogen atom or independently of one another - 4 alkyl group
- X gg is Iou atom, an oxygen atom, CH- N_ ⁇ 2 group or N-R 5 gg group (wherein R 5 gg is hydrogen atom, a hydroxyl group, _ 4 alkoxy groups, C 1 _ 4 alkyl group, Shiano group or - 4 alkylsulfonyl group
- argG is halogen atom, C, _ 4 alkyl group, C, _ 4 alkoxy group, - 4 Ashiru group, Shiano group, a nitro group, A pyridyl group or a phenyl group which may have one or more substituents selected from
- the compound or a salt thereof is produced by the method described in JP-A-5-148228 ( ⁇ - ⁇ -5 16520) or a method analogous thereto.
- R 1 hh is - 4 alkyl group
- R 2 hh is C 5 _ 7 cycloalkyl group, e 5 _ 7 cycloalkyl - methyl group, a benzyl group, or _ 4 alkyl group
- a hh is an oxygen atom or a methylene group
- B hh is a direct bond, a methylene group or a carbonyl group
- a hh is a pyridyl group
- R 3 hh and R 4 hh are independently of each other hydrogen, halogen atom, nitro group, C, _ 4 alkyl group, - 4 alkoxy group, means a phenyl group or a triflate Orometokishi group), the following formula Oxofluorenyl group,
- n hh represents 1 or 2
- X hh represents an oxygen atom or an iodine atom.
- the compound represented by these, or its salt are 1 _ [2 — [2— (N-benzyl-N-methylamino) ethoxy] ethyl] 1-3- (3-nitrobenzoyl) thiourea, 1— [2— [2— (N— Benzyl-N-meth Lumino) ethoxy] ethyl] 1-3- (9-oxo-2-fluorenol) thiourea.
- the above compound or a salt thereof is produced by the method described in JP-A-5-194359 (EP-A-5 26313) or a method analogous thereto.
- i is C 5 - 7 cycloalkyl group, phenyl group or a 4 ⁇ alkyl group, - 4 phenyl group substituted with an alkoxyl group or a halogen atom;
- R 2 ii is hydrogen or _ 4 alkyl group
- X ii is an oxygen atom or a thio atom;
- a ii is a methylene group, a carbonyl group or a sulfonyl group;
- R 3 is
- R 4 i; and R 5 i independently of one another, represent a hydrogen, a halogen atom, a nitro group, a _ 4 alkyl group, a _ 4 alkoxyl group, a — 4 acyl group, a benzoyl group, a — 4 alkylsulfonyl And R 4 ;; and R 5 ii together form a methylenedioxy group) or a group represented by the formula:
- a ii represents a group other than a methylene group.
- Specific examples are 1- (3-nitrobenzoyl) 1-3- [2- (1-benzyl-4-piperidyl) ethyl] thiourea, 1- (9,10-dioxo-2-anthracenoyl) 1-3- [ 2- (1-benzyl-4-piperidyl) ethyl] thiourea and the like.
- the above compound or a salt thereof is produced by the method described in JP-T-6-507387 (W92 / 1 4710) or a method analogous thereto.
- Xjj is independently hydrogen, lower alkyl, aryl, aryloxy, CN, lower alkoxy, halogen, hydroxy, nitro, trifluoromethyl, alkylsulfonamide, NHCOR JJ (where R JJ is lower alkyl or aryl), NR JJ R 2 j ” ⁇ J and R 2 jj are independently hydrogen or lower alkyl, or together form a ring), C 0 2 R j 5 (where R j i is lower alkyl), or optionally, Y jj is CO or CR 3 ”j R 4 ′ j, wherein Y jj is one or more substituents selected from cycloalkyl, cycloalkenyl or bicycloalkyl further substituted by lower alkyl; , R 3 jj Oyopi 4 jj independently water , Lower alkyl, or lower al
- Is a 4_chlorophenyl its stereoisomers, optical isomers, racemates or salts thereof.
- Specific examples include 5-cyclohexyl-1,3-dihydro-1- [2- [1- (phenylmethyl) -4-piberidinyl] ethyl] -2H-indole-21one.
- the above compound or a salt thereof is produced by the method described in Japanese Patent Publication No. 7-502272 (WO 93/1 2085) or a method analogous thereto.
- n kk is 3, 4, 5, 6 or 7;
- X kk is independently hydrogen, lower alkyl , Aryl, lower alkoxy, halogen, trifluoromethyl, nitro,
- NHC ⁇ R kk (where R kk is lower alkyl or aryl), one NR! kk R 2 kk (where Ri kk and R 2 kk are independently hydrogen or lower alkyl, or together form a ring), or, optionally, further substituted by lower alkyl cycloalkyl, one or more substituents cycloalkenyl Wakashi Ku is selected from bicycloalkyl; 1 ⁇ is Rei_0 or ⁇ R 3 k k R 4 kk (where, R 3 kk and R 4 kk is independently Z kk is a lower alkyl; and Wkk is independently selected from hydrogen, lower alkyl, lower alkoxy, or halogen; hydrogen, lower alkyl, lower alkoxy, or together form a cyclic acetal); Is one or more substituents.
- 5-cyclohexyl_1,3-dihydro_1-11 [5- (N-ethyl-N-phenylmethylamino) pentyl] -12H-indole-2_one
- 5-cyclo Hexyl 1- [5- (N-ethyl-N-phenylmethylamino) pentyl] —1H-indole-2,3-dione.
- the above compound or a salt thereof is produced by the method described in JP-T-8-511515 (WO 94/29272) or a method analogous thereto.
- substituent group A11 a group selected from the following substituent group A11, or 1 to 3 substituents (same or different) selected from the following substituent group A11, respectively.
- p11 is an integer of 1 to 3 Show.
- U 11 is a group represented by the formula: —CO— or —CH ( ⁇ R 3 ,,) — (wherein R.,, and represent a hydrogen atom or a hydroxyl-protecting group.
- a group represented by NR 5 JJR 6 j J (wherein, R 5 i, and R 6 !! are each a hydrogen atom, a group selected from Substituent Group A 11 below, or a Substituent Group A 11 below) Represents an aryl group, an arylcarbonyl group, an aralkyl group, a heterocyclic group or a heterocyclic alkyl group optionally having 1 to 3 selected substituents (same or different). ).
- the compound represented by these, or its salt include 1-methyl-3- [3- (1-benzyl-4-piperidyl) propionyl] indole and 1-methyl-3_ [3- [1- (3-fluorobenzyl) -14-piperidyl] propionyl] 1.5 —Fluoro India , 1-methyl-3- [3- [1- (2-chlorobenzyl) -14-piberidyl] propionyl] indazole and the like.
- the compound or a salt thereof is produced by the method described in JP-A-6-41070 (EP-A-562832) or a method analogous thereto.
- R 1 mm is a hydrogen atom, a halogen atom, an alkyl group, an alkoxy group or an alkylthio group
- R 2 mm is a hydrogen atom, a halogen atom, an alkyl group or an alkoxy group
- n mm is an integer of 0 to 7; Indicates that a double bond may be present.
- the above compound or a salt thereof is produced by the method described in JP-A-5-9188 or a method analogous thereto.
- n nn is an integer from 0 to 7
- R 1 nn is a hydrogen atom, a halogen atom, an alkyl group, an alkoxy group or an alkylthio group
- R 2 nn is a hydrogen atom, a halogen atom, a hydroxyl group, an alkyl group, an alkoxy group, or a substituent
- R 3 nn represents a hydrogen atom, a halogen atom, an alkyl group or an alkoxy group
- mnn represents an integer of 1 to 3.
- the above compound or a salt thereof is produced by the method described in JP-A-5-279355 (EP-A-481429) or a method analogous thereto.
- R. . Is hydrogen, alkyl, alkenyl, cycloalkylalkyl, Hue Niruarukiru, naphthylalkyl, cycloalkylalkenyl, Fueniruaru Kenyir or naphthyl alkenyl; R l 0 °, R 2 ° °, R 3 ° ° and R 4 ° ° are the same or different And hydrogen, halogen, alkyl, phenyl, phenylalkyl, alkoxy, heteroaryl, heteroarylalkyl, phenylalkoxy, phenoxy, heteroarylalkoxy, heteroaryloxy, acyl, acysiloxy, hydroxyl, nitro, cyano, —NHCOR, respectively 5 ° °, -S (O) moo R 5 ° °, one NHS_ ⁇ 2 R 5 °.
- R 9 .. is alkyl, phenyl or phenyl alkyl; R 6 ° ° and R 7 ° ° are the same or different and each represent hydrogen, alkyl, phenyl or phenyl alkyl, or represents an adjacent nitrogen atom.
- R 8 ° is alkyl, phenyl or phenylalkyl
- R 9 ° is hydrogen, alkyl, phenylalkyl or acyl
- m 00 is 0, 1 or 2
- p.oo, qoo, roo and soo are the same or different and represent 1, 2, or 3
- A00 is straight-chain or ' Alkylene, alkenyl, alkoxy, phenyl, phenoxy, cycloalkylalkyl, phenylalkyl, naphthylalkyl, cycloalkylalkenyl, phenylalkenyl, naphthylalkenyl, phenylene
- n00 is 1, 2, or 3
- enyl alkoxy, Heteroariru, hetero aryl O alkoxy, heteroalkyl ⁇ reel alkyl, hetero ⁇ reel alkoxycarbonyl, benzene ring and heteroaromatic ring are
- the compound or a salt thereof is produced by the method described in JP-A-5-320160 (W 93/0 4063) or a method analogous thereto.
- R app is represented by the formula
- R p is hydrogen, alkyl, alkenyl, cycloalkylalkyl, cycloalkylalkenyl, phenylalkyl, phenylalkenyl, naphthylalkyl or naphthylalkenyl;
- a p is a linear or branched alkylene 110 represents 1, 2, or 3), and
- R bpp represents oxygen.
- R app is absent and R bpp is of the formula
- R lpp , R 2 pp , R 3 pp and R 4 pp are the same or different , Respectively, hydrogen, halogen, alkyl, alkoxy, phenyl, phenylalkyl, phenylalkoxy, phenoxy, heteroaryl, heteroarylalkyl, heteroarylalkoxy, heteroaryloxy, acyl, acyloxy, hydroxyl, nitro, cyano, — NHCOR 5 pp , -S (0) mpp R 5 pp, -NHS0 2 R 5 pp, - C_ ⁇ _NR 6 pp R 7 pp, one NR 6 pp R 7 p p, -OCSNR 6 pp R 7 pp, -S0 2 NR 6 pp R 7 pp or a CO OR 8 Indicates pp .
- R 5 pp is alkyl, phenyl or phenylalkyl
- R 6 pp and R 7 pp are the same or different and each represents hydrogen, alkyl, phenyl or phenylalkyl, or binds to an adjacent nitrogen atom.
- R 8 pp represents hydrogen, alkyl, phenyl or phenylalkyl; mpp represents 0, 1 or 2; in the above definition, alkyl, alkenyl, alkoxy, phenyl, phenylalkyl, Phenylalkenyl, phenylalkoxy, phenoxy, cycloalkylalkyl, cycloalkylalkenyl, naphthylalkyl, naphthylalkenyl, heteroaryl, heteroaryl
- heteroarylalkoxy and heteroaryloxy include halogen, alkyl, alkoxy, acyl, acyloxy, hydroxyl, nitro, cyano,
- NHCOR 5 pp one S ( ⁇ ) mpp R 5 pp, - NHS0 2 R 5 pp, -CON R 6 pp R pp ⁇ -? NR 6 pp R 7 pp, -OCONR 6 pp R 7 pp, -O CSNR 6 pp R 7 pp, -S0 2 NR 6 pp R 7 pp or one COOR 8 p
- R 5 pp ⁇ R 6 pp 3 ⁇ 4R 7 pp 3 ⁇ 4R 8 pp and m pp are as defined above) and may have 1 to 3 substituents.
- the compound represented by these, or its salt include 3- [2- (1-benzyl-4-piperidyl) ethyl] -6,7-dimethoxy-1,2-benzoisoxazole, 6-benzoylamino-2— [3- (1- Benziru 4-piperidyl) propyl]
- the compound or a salt thereof is produced by the method described in JP-A-6-41125 (WO 93/04 063) or a method analogous thereto.
- R 1 qg is hydrogen, lower alkyl, a heterocyclic group which may have a substituent or an aryl which may have a substituent
- R 2 qq is hydrogen, a lower alkyl, A heterocyclic group which may have a substituent or an aryl which may have a substituent
- R 1 qq and R 2 qq are bonded to each other to form a group represented by the formula:
- Zqq represents S or O, respectively) a group represented by the formula:
- R 1 qq and R 2 qq are as defined above; W qq is a bond, lower alkylene or lower alkenylene; Yqq is lower alkylene, —NH—, —CO— , -CONR 3 qq-where R 3 qq represents hydrogen or lower alkyl, or a group or formula: — CHR 7 q Q-(where R 7 qq represents hydroxy or protected hydroxy)
- Aqq is a bond or a lower alkyl group
- Qqq is a group or a formula of the formula: NR 8 qq R 9 qq , wherein R 8 qq is lower alkyl; R 9 qq is ar (lower) alkyl.
- R 4 qq represents lower alkyl or ar (lower) alkyl which may have a substituent).
- the compound represented by these, or its salt include 4- (pyridine-3-yl) -1-5-methyl-2-[[2- (1-benzylpiperidine-4-yl) ethyl] rubambamoyl] thiazol, 2-[[ 2- (1-Benzylpiperidine-4-yl) ethyl] l-bamoyl] -1-4- (4-chlorophenyl) -5-methyloxazole, 5 -— [[2- (1—benzylpiperidine-4- Yl) ethyl] rubamoyl]-3-(4-to-n-phenyl) pyrazols and the like.
- the above compound or a salt thereof is produced by the method described in JP-A-5-345772 or a method analogous thereto.
- R 1 rr is a lower alkyl, a heterocyclic group which may have a substituent, an aryl which may have a substituent, an alkyl (lower) alkyl which may have a substituent Or ar (lower) alkenyl;
- Q rr is oxaziazol diyl;
- Z rr is a bond or vinyl;
- X rr is a bond; formula: — CONR 4 rr — (wherein R 4 rr represents hydrogen or lower alkyl) ), Formula: — CHR 8 rr — (wherein, R 8 rr represents hydroxy or protected hydroxy), one CO— or —NHC 0—;
- a rr is a bond, lower alkylene or lower alkenylene;
- M rr Contains at least one nitrogen atom optionally having one substituent selected from the group consisting of lower alkyl, imino protecting group and optionally substituted (lower) alkyl
- the above compound or a salt thereof is produced by the method described in Japanese Patent Publication No. 7-502529 (WO 93/1 3083) or a method analogous thereto.
- J ss represents (a) a substituted or unsubstituted group shown below; (1) phenyl, (2) pyridyl, (3) pyrazyl, (4) quinolyl, and (5) cyclohexyl.
- a monovalent or divalent group selected from the following groups in which the phenyl group may be substituted; (1) indanyl, (2) indanonyl, (3) indul, (4) indenonyl, (5) Indanzionyl, (6) tetralonyl, (7) benz suberonyl, (8) indanolyl, formula (9)
- T ss means a nitrogen atom or a carbon atom.
- Q ss represents a nitrogen atom, a carbon atom or a group represented by the formula> N ⁇ 0.
- Kss is a hydrogen atom, a substituted or unsubstituted phenyl group, a substituted or unsubstituted arylalkyl group, a phenyl group optionally substituted cinnamyl group, a lower alkyl group, a pyridylmethyl group, a cycloalkylalkyl Group, adamantanemethyl group, furylmethyl group, cycloalkyl group, lower alkoxyl propyl group or acryl group.
- q ss means an integer of 1 to 3.
- the above compound or a salt thereof is produced by the method described in JP-A-64-79151 (US Pat. No. 4,895,841) or a method analogous thereto.
- R 1 tt represents benzene, pyridine, pyrazine, indole, anthraquinone, quinoline, phthalimide which may have a substituent, Imide, pyridine carboxylic acid imide, pyridine mono-N-oxide, pyrazine dicarboxylic imide, naphthylene dicarboxylic imide, quinazolidinedione optionally having a substituent, 1,8-naphthalimide, bicyclo
- X tt is of the formula (CH 2) mtt- tt represents an integer of 0 to 7), a group represented by the formula: (CH 2 ) n tt-, a group represented by the formula —S (CH 2 ) ntt—, a formula represented by —NH (CH 2 ) n
- a group represented by R 2 tt is a hydrogen atom, a lower alkyl group, an optionally substituted benzyl group, an optionally substituted benzoyl group, a pyridyl group, a 2-hydroxyxyl group , A pyridylmethyl group, or a formula
- Z tt represents a halogen atom.
- the compound represented by these, or its salt include N-methyl-N-C2-(— benzylbiperidine-4′-yl) ethyl] —4-benzylsulfonylpentazamide, N— [2- (N′-benzylpiperidine-1 4′-one) Yl) 1-412 trophtalimide, N- [2- (N'-benzylpiperidine-14'-yl) ethyl] 1,8,1-naphthalimide.
- the above compound or a salt thereof is produced by the method described in JP-A-62-234065 (EP-A-229391) or a method analogous thereto.
- R 1 uu is a group derived from a cyclic amide compound which may have a substituent; n uu is 0 or an integer of 1 to 10;
- R 2 uu represents an aryl group which may have a substituent, a cycloalkyl group or a heterocyclic group; m uu represents an integer of 1 to 6), or 2)
- R 3 u u is a hydrogen atom or a lower alkyl group
- R 4 u u is an aryl group, a cycloalkyl group, or a heterocyclic group which may have a substituent; Which means an integer
- the cyclic amide compound which may have a substituent in the definition of R 1 uu is quinazolidin-one or quinazolidin-dione
- R 2 "u and R 4 uu are A compound represented by the formula: or a salt thereof.
- n ww is 0 or an integer of 1 to 2;
- C ww is a hydrogen atom or a hydroxy group
- D ww is a hydrogen atom or a lower hydroxyalkyl group
- R ww is the same or different and is a group selected from a hydrogen atom, a lower alkyl group and a lower alkoxy group
- mw Represents 0 or an integer of 1 to 4
- B ww represents a hydrogen atom or a hydroxy group
- a w and B ww form a double bond
- the above compound or a salt thereof is produced by the method described in JP-A-9-1268176, or a method analogous thereto.
- R lxa is hydrogen, halogen, hydroxy, lower alkoxy, lower alkyl, or mono (or di or tri) halo (lower) alkyl
- R 2xa and R 3XA each represents a lower alkyl group.
- R 2xa and R 3XA each represents a lower alkyl group.
- the compound represented by these, or its salt include 9-amino-6-chloro-3,3-dimethyl-1,2,3,4-tetrahydroacridine.
- the compound or a salt thereof is produced by the method described in JP-A-2-167267 or a method analogous thereto.
- R lx and R 2xb and R 3xb are each a hydrogen atom, a halogen atom, a trifluoromethyl group, a lower alkyl group, a lower cycloalkyl group, a lower alkoxy group, a lower alkoxymethyl group, a lower alkylthio group, a nitro group, an amino group.
- R 4xb is a hydrogen atom, a lower alkyl group, an aralkyl group, a diaralkyl group, or a compound of the formula R 5xb -c ⁇
- R 5xb represents a lower alkyl group, a lower cycloalkyl group, an aralkyl group, a phenyl group, or a phenyl group substituted with a halogen atom, a lower alkyl group or a lower alkoxy group.
- R 5xb represents a lower alkyl group, a lower cycloalkyl group, an aralkyl group, a phenyl group, or a phenyl group substituted with a halogen atom, a lower alkyl group or a lower alkoxy group.
- a salt thereof include 9-amino-8-fluoro-1,2,3,4-tetrahydro-1,4-ethano-1-azacridine.
- the above compound or a salt thereof is produced by the method described in JP-A-63-166881 or a method analogous thereto.
- R lxc represents a hydrogen atom or a lower alkyl group
- R 2xc independently represents a hydrogen atom or a lower alkyl group, or forms a cyclic alkyl group together with R 6xe.
- R 3xe and R 4 commonlyeach independently represent a hydrogen atom, or together form a quinoline ring or a tetrahydroquinoline ring together with ring
- a xc X xc represents an oxygen atom, a sulfur atom or N— indicates R 5xc, R 5xe is.
- Y xc showing a water atom or a lower alkyl group indicates an oxygen atom or ⁇ - R 6xe
- R 6xc is independently a hydrogen atom or a lower alkyl group, Or a cyclic alkylene together with R 2xc
- nxc is 0 or 1
- mxc is an integer of 0 to 4.] or a salt thereof, specifically, 4′-aminoquinolino [2,3-b] —4-Methyl-5,6-dihydro-1,4-oxazine and 4′-amino-5 ′, 6 ′, 7 ′, 8′-tetrahydroquinolino [2,3- b] —4-Methyl-5,6-dihydro-1,4-oxazine.
- the above compound or a salt thereof is produced by the method described in JP-A-2-96580 or a method analogous thereto.
- Xxd is hydrogen, lower alkyl, lower alkoxy, halogen, hydroxy, di- or trifluoromethyl;
- R lxd and R 2xd are each independently hydrogen
- R 3xd and R 4xd are each independently hydrogen, lower alkyl, aryl lower alkyl, or lower alkyl or aryl lower alkyl, but both cannot be aryl lower alkyl at the same time;
- the above compound or a salt thereof is produced by the method described in JP-A-3-153667 or a method analogous thereto.
- nx e is 1, 2 or 3
- X xe is hydrogen, (: ⁇ -C 6 -alkyl, -C 6 -alkoxy, halogen, hydroxy, nitro, trifluoromethyl,
- NHCOR 2xe (where R 2xe is CC 6 -alkyl) or NR 3xe R 4xe (where R 3xe and R 4xe are independently hydrogen or CC 6 -alkyl) and R xe is hydrogen or -C 6 - alkyl
- R LXE is hydrogen, C 1 -C 6 primary alkyl, di - -C 6 - Arukiruamino - -C 6 - ⁇ alkyl, Ariru - -C 6 - alkyl, Jiari one Lou ⁇ c 6 primary alkyl, furyl - -C 6 - alkyl, Choi two Lou d ⁇ c 6 - alkyl, oxygen bridged ⁇ Li one Roux to c 6 - alkyl, oxygen bridged Jiariru to c 6 - alkyl, oxygen Bridged furyl- ⁇ c 6 -alkyl, or oxygen-bridged C 2 -d 6 -alkyl, where Y
- nx f is an 1 to 4;
- R xf is hydrogen, lower alkyl or lower alkyl Rukaruponiru;
- R LXF is hydrogen, lower alkyl, lower alkyl force Ruponiru, Ariru, di-lower Arukiruamino lower alkyl, Ariru lower Alkyl, diaryl lower alkyl, oxygen bridged aryl lower alkyl, or oxygen bridged diaryl lower alkyl;
- Ax f is a direct bond or (CHR 3xf ) mx f; mx f is 1-3 Yes;
- Xx f is hydrogen, lower alkyl, cycloalkyl, lower alkoxy, halogen, hydroxy, nitro, trifluoromethyl, formyl, lower alkylcarbonyl, arylalkyl, one SH, lower alkylthio, one NHCOR 4 ⁇ or NR 5xf R 6xf Wherein R 4xf is hydrogen or lower al
- a stereo, optical or geometric isomer thereof, or a salt thereof include 9-amino-2,3-dihydrocheno [3,2-b] quinoline and 10-amino-3,4-dihydro-1H-thiopyrano [4,3-b] quinoline.
- the above compound or a salt thereof is produced by the method described in JP-A-63-284175 or a method analogous thereto.
- xxG is hydrogen, lower alkyl, lower alkoxy or halogen
- R xg is, when present is hydrogen, lower alkyl or Ariru lower alkyl
- R LXG is hydrogen, lower alkyl or Ariru lower Alkyl
- R 2xg when present, is hydrogen or lower alkyl.
- the compound represented by these, or its salt Specifically, 2- (1,2,3,4-tetrahydro-9-acrylidine) monocyclohexanecarboxylic acid or 2- (1,2,3,4-tetrahydro-9-acrylidine) Mino) -cyclohexanecarboxylic acid ethyl ester and the like.
- the above compound or a salt thereof is produced by the method described in JP-A-3-951161 or a method analogous thereto.
- R lxh and R 2xh represent a hydrogen atom, a halogen atom, a lower alkyl group, a trifluoromethyl group, a hydroxyl group, a lower alkoxy group, a lower alkoxy group, a nitro group, an amino group or a lower alkanoy, respectively.
- R 3xh represents a hydrogen atom; an alkyl group having 1 to 15 carbon atoms; a cycloalkyl group; an aralkyl having 7 to 15 carbon atoms which may be substituted with halogen, lower alkyl group or lower alkoxy.
- a benzoyl group which may be substituted with halogen, lower alkyl, lower alkoxy, nitro, hydroxyl or amino; n X h represents an integer of 2 to 5; You. ] Or a salt thereof. Specifically, 6-amino-1-benzyl-1,2,3,4,5-tetrahydro-1H-azepino [2,3-b] quinoline and 5-amino-1-6-fluoro-1,2,3,4- Tetrahydrobenzo [d- [1, 8] naphthyridine.
- the above compound or a salt thereof is produced by the method described in JP-A-3-220189 or a method analogous thereto.
- R lxi and R 2xi each represent a hydrogen atom, a linear or branched alkyl group having 1 to 4 carbon atoms. However, they are not both hydrogen atoms.
- the compound or a salt thereof is produced by the method described in JP-A-4-134083 or a method analogous thereto. 34) Expression
- Ax j represents an alkylene group of the formula — (CH 2 ) nx j-(where nx j is an integer of 3 to 5), and two adjacent carbon atoms of the adjacent pyridine nucleus Or forms one cycloalkeno group, or Ax j is a group that associates with two adjacent carbon atoms of the adjacent pyridine nucleus to form one benzene ring, and ( i) When Ax j forms a cycloalkeno group, Yx j represents a hydrogen atom, a halogen atom, a d-C 6 lower alkyl group or an amino group, and Zx j is a hydrogen atom, a hydroxyl group, a halogen atom, an amino group, the formula -NR lx] R 2xj (R lxj , R 2xj may be the same or different, lower alkyl group or a benzyl group represents a) group, a pyrrolid
- B represents an oxygen atom or a sulfur atom
- mx j represents an integer of 0 to 2
- R 3xj , R 4xj , and R 5xj may be the same or different and may be a hydrogen atom, a halogen atom, a trifluoro group.
- the above compound or a salt thereof is produced by the method described in JP-A-4-66571 or a method analogous thereto.
- R xk is hydrogen, alkyl, aralkyl or acyl
- R lxk and R 2xk are independently hydrogen, alkyl, aralkyl, alkoxy, alkoxyl propyl, amino or 1 or 2 alkyl
- An amino substituted with an aralkyl or an acyl group, 111 11 and 11] ⁇ are 1, 2 or 3, and ⁇ :: ⁇ ⁇ !
- ⁇ Is independently a bond between two carbons, an oxygen or sulfur atom, a group N—R 3xk (wherein the group R .3xk has the meaning defined above for R xk ) or 1 to 5 Alkylene or alkenylene bridge which contains one or more substituents R 4xk , wherein R 4xk is independently hydrogen, linear or branched having 1 to 4 carbon atoms Substituted by a branched lower alkyl, alkenyl or alkylidene, phenyl or lower alkyl group having 1 or 2 or more carbon atoms, lower alkoxy group having 1 to 4 carbon atoms or halogen group Phenyl, aralkyl, lower alkoxy having 1 to 4 carbon atoms, and hydroxyl) and Xx When k is a arkenylene group, the latter can be fused to a saturated or unsaturated carbocyclic or heterocyclic ring system, wherein the ring is one or more groups R Sxk
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Urology & Nephrology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Description
Claims
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA002531019A CA2531019A1 (en) | 2003-06-30 | 2004-06-29 | Preventive/remedy for urinary disturbance |
EP04746955A EP1640021A4 (en) | 2003-06-30 | 2004-06-29 | PREVENTIVE / MEDICAMENT FOR URINARY DISTURBANCE |
US10/560,754 US20070021391A1 (en) | 2003-06-30 | 2004-06-29 | Preventive/remedy for urinary disturbance |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2003-188761 | 2003-06-30 | ||
JP2003188761 | 2003-06-30 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2005000354A1 true WO2005000354A1 (ja) | 2005-01-06 |
Family
ID=33549764
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2004/009486 WO2005000354A1 (ja) | 2003-06-30 | 2004-06-29 | 排尿障害予防・治療剤 |
Country Status (4)
Country | Link |
---|---|
US (1) | US20070021391A1 (ja) |
EP (1) | EP1640021A4 (ja) |
CA (1) | CA2531019A1 (ja) |
WO (1) | WO2005000354A1 (ja) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007070961A1 (en) * | 2005-12-21 | 2007-06-28 | Cortical Pty Ltd | Mif inhibitors |
US20110014283A1 (en) * | 2007-03-01 | 2011-01-20 | Allan James Clarke | Novel dosage form |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI287984B (en) * | 2000-10-17 | 2007-10-11 | Wyeth Corp | Pharmaceutical composition for modulating bladder function |
US20060135507A1 (en) * | 2004-08-13 | 2006-06-22 | Osamu Yokoyama | Therapeutic agent for overactive bladder involved in aging |
US20060172992A1 (en) * | 2004-08-13 | 2006-08-03 | Eisai Co., Ltd. | Therapeutic agent for overactive bladder resulting from cerebral infarction |
JP5524624B2 (ja) * | 2007-11-16 | 2014-06-18 | 旭化成ケミカルズ株式会社 | 水系フィルムコーティング液、および、フィルムコーティング顆粒、ならびに、これを用いた錠剤 |
CN101983055B (zh) * | 2008-01-31 | 2013-05-08 | 杏林制药株式会社 | 以咪达那新为有效成分的口腔内速崩片的制造方法 |
WO2010082912A1 (en) * | 2009-01-15 | 2010-07-22 | Avalon Pharmaceuticals | Derivatives of multi-ring aromatic compounds and uses as anti-tumor agents |
KR20180074707A (ko) * | 2015-10-15 | 2018-07-03 | 모세 로고스니츠키 | 저 용량 경구 디피리다몰 조성물 및 이의 용도 |
CN107459527B (zh) * | 2017-09-22 | 2019-07-05 | 中国科学院烟台海岸带研究所 | 一种六环生物碱类化合物及其制备和应用 |
CN107652305B (zh) * | 2017-09-22 | 2019-07-26 | 中国科学院烟台海岸带研究所 | 一种吲哚氰基生物碱类化合物及其制备和应用 |
CN107629070B (zh) * | 2017-09-22 | 2019-07-19 | 中国科学院烟台海岸带研究所 | 一种氨基甲酸酯类化合物及其制备和应用 |
EP4210703A1 (en) * | 2020-09-08 | 2023-07-19 | Expansion Therapeutics, Inc. | Small molecules that target the rna that causes als |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH07206854A (ja) * | 1993-01-18 | 1995-08-08 | Takeda Chem Ind Ltd | 三環式縮合複素環誘導体、その製造法および用途 |
JP2000169373A (ja) * | 1998-09-30 | 2000-06-20 | Takeda Chem Ind Ltd | 膀胱排出力改善剤 |
WO2003057254A1 (fr) * | 2001-12-28 | 2003-07-17 | Takeda Chemical Industries, Ltd. | Produits preventifs/remedes contre les troubles urinaires |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US177593A (en) * | 1876-05-16 | Improvement in butter-packages | ||
TW248556B (ja) * | 1993-01-18 | 1995-06-01 | Takeda Pharm Industry Co | |
US20020177593A1 (en) * | 1998-09-30 | 2002-11-28 | Yuji Ishihara | Agents and crystals for improving excretory potency of urinary bladder |
EP1891954A3 (en) * | 1998-09-30 | 2009-01-14 | Takeda Pharmaceutical Company Limited | Acetylcholinesterase inhibitors for improving excretory potency of urinary bladder |
-
2004
- 2004-06-29 EP EP04746955A patent/EP1640021A4/en not_active Withdrawn
- 2004-06-29 CA CA002531019A patent/CA2531019A1/en not_active Abandoned
- 2004-06-29 WO PCT/JP2004/009486 patent/WO2005000354A1/ja not_active Application Discontinuation
- 2004-06-29 US US10/560,754 patent/US20070021391A1/en not_active Abandoned
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH07206854A (ja) * | 1993-01-18 | 1995-08-08 | Takeda Chem Ind Ltd | 三環式縮合複素環誘導体、その製造法および用途 |
JP2000169373A (ja) * | 1998-09-30 | 2000-06-20 | Takeda Chem Ind Ltd | 膀胱排出力改善剤 |
WO2003057254A1 (fr) * | 2001-12-28 | 2003-07-17 | Takeda Chemical Industries, Ltd. | Produits preventifs/remedes contre les troubles urinaires |
Non-Patent Citations (1)
Title |
---|
See also references of EP1640021A4 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007070961A1 (en) * | 2005-12-21 | 2007-06-28 | Cortical Pty Ltd | Mif inhibitors |
US20110014283A1 (en) * | 2007-03-01 | 2011-01-20 | Allan James Clarke | Novel dosage form |
Also Published As
Publication number | Publication date |
---|---|
EP1640021A4 (en) | 2008-01-23 |
US20070021391A1 (en) | 2007-01-25 |
EP1640021A1 (en) | 2006-03-29 |
CA2531019A1 (en) | 2005-01-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US8252814B2 (en) | Agents and crystals for improving excretory potency of urinary bladder | |
AU758802B2 (en) | Drugs for improving vesical excretory strength | |
US7462628B2 (en) | Preventives/remedies for urinary disturbance | |
JP2001226269A (ja) | メラニン凝集ホルモン拮抗剤 | |
WO2005000354A1 (ja) | 排尿障害予防・治療剤 | |
EP1310490A1 (en) | Gpr14 antagonist | |
JP2005035996A (ja) | 排尿障害予防・治療剤 | |
JP3512786B2 (ja) | 膀胱排出力改善剤 | |
JP2000169373A (ja) | 膀胱排出力改善剤 | |
JP2003335701A (ja) | 排尿障害予防治療剤 | |
JP3986423B2 (ja) | 膀胱排出力改善剤 | |
JP2007016039A (ja) | 排尿障害予防治療剤 | |
JP2001335576A (ja) | 三環式縮合複素環誘導体の結晶 | |
JP2006104208A (ja) | 排尿障害予防治療剤 | |
MXPA01003286A (en) | Drugs for improving vesical excretory strength |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2004746955 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2007021391 Country of ref document: US Ref document number: 10560754 Country of ref document: US |
|
ENP | Entry into the national phase |
Ref document number: 2531019 Country of ref document: CA |
|
WWP | Wipo information: published in national office |
Ref document number: 2004746955 Country of ref document: EP |
|
NENP | Non-entry into the national phase |
Ref country code: JP |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: JP |
|
WWP | Wipo information: published in national office |
Ref document number: 10560754 Country of ref document: US |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 2004746955 Country of ref document: EP |